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Liao, Pin-Chao. Ph.D., Purdue University, December 2016. ROS Regulation of Axonal 
Mitochondrial Transport. Major Professor: Peter J. Hollenbeck. 
 
 
    Mitochondria perform critical functions including aerobic ATP production and calcium 
(Ca2+) homeostasis, but are also a major source of reactive oxygen species (ROS) 
production. To maintain cellular function and survival in neurons, mitochondria are 
transported along axons, and accumulate in regions with high demand for their functions. 
Oxidative stress and abnormal mitochondrial axonal transport are associated with 
neurodegenerative disorders. However, we know little about the connection between 
these two. Using primary Drosophila neuronal cell culture and the third instar larval 
nervous system as in vitro and in vivo models, respectively, we studied mitochondrial 
transport under oxidative stress conditions. In vitro, hydrogen peroxide (H2O2) 
diminished the percentage of moving mitochondria, the mitochondrial length and inner 
membrane potential. In vivo, ROS inhibited specifically mitochondrial axonal transport, 
primarily due to reduced flux and velocity, but did not affect transport of other organelles. 
In addition to excess ROS, down-regulation of Nox or Duox expression, which reduces 
endogenous ROS levels, mitochondrial transport was impaired. To understand the 
mechanisms underlying these effects, we examined Ca2+ levels and the JNK (c-Jun N-
terminal Kinase) pathway, which have been shown to regulate mitochondrial transport 
and general fast axonal transport, respectively. We found that elevated ROS increased 
Ca2+ levels, and that the Ca2+ chelator EGTA rescued ROS-induced defects in 
mitochondrial transport. In addition, activation of the JNK pathway reduced 
mitochondrial flux and velocities, while JNK knockdown partially rescued ROS-induced 






mitochondrial traffic, and that Ca2+ and JNK signaling play roles in mediating these 









CHAPTER 1. INTRODUCTION 
1.1 Mitochondrial transport in neurons 
 
1.1.1 Importance of mitochondrial transport in neurons 
    Neurons have an exceptional cellular morphology because of their asymmetry and long 
length. This somato-dendritic, axonal, and synaptic terminal regions have 
compartmentalized differences in molecular machinery and signaling. The cell body is 
the crucial region for synthesis and degradation of proteins or organelles, but axonal 
regions also have low levels of protein synthesis. Thus, it is a thought that after protein 
synthesis in the soma, cargoes are transported from the soma to the synaptic terminals 
(anterograde transport), and accumulate in regions with high demand for their functions. 
When materials are aged, they could be transported back to the cell body for recycling or 
degradation (retrograde transport) (Saxton and Hollenbeck, 2012) (Fig. 1.1A).  
    Among all neuronal cargoes, mitochondria are one of the important organelles. 
Mitochondria are the source of aerobic ATP production for the cell and also contribute to 
calcium (Ca2+) homeostasis. Neurons need large amounts of ATP to maintain their high 
metabolism. Among the different regions of neurons, synapses have among the highest 
demand for mitochondrial ATP. When a synaptic vesicle releases neurotransmitter, 
hundreds of postsynaptic channel open and lots of ions enter the cell. To maintain the ion 
gradients, ATP is required for pumping them back across the plasma membrane (Schwarz, 
2013). In addition to the synapse, action potentials also require energy to maintain ion 
gradients. Two groups have provided evidence that in myelinated nerves, increased 
electric activity decreases mitochondrial transport in the node of Ranvier or paranodal 
region. Without stimuli, most stationary mitochondria localize in the internodal or 





 and other mitochondrial functions such as Ca2+ buffering in this region of the nerve is 
presented to underlie this localization, and I conclude that correct distribution and 
transport of mitochondria is crucial for nerves. 
 
1.1.2 Behaviors of mitochondrial transport 
    Different axonal organelles or cargoes have their preferred dominant direction of 
transport. For example, fast-moving axonal vesicles containing neuropeptides 
preferentially move anterogradely (Barkus et al., 2008). On the other hand, the dominant 
direction of autophagosomes and organelles carrying endocytic cargoes is retrograde 
(Hollenbeck, 1993; Maday et al., 2012). 
    Axonal mitochondria exhibit unique transport behaviors, with about 70% of them 
being stationary and 30% motile (Morris and Hollenbeck, 1993; Pilling et al., 2006; 
Devireddy et al., 2015). In the motile population, about 2/3 move anterogradely and 1/3 
move retrogradely. In the long distance movement, mitochondria usually move with 
continuous runs intermixed with short pauses or oscillations. They sometimes change 
direction for a short period but retrun to movement in their primary direction; completely 
reversed directions are rare (Morris and Hollenbeck, 1993; Pilling et al., 2006; Devireddy 
et al., 2015). These unique transport behaviors are regulated by motor proteins, adaptor 
proteins, and anchor proteins, which are described in the following sections. 
 
1.1.3 Key proteins for mitochondrial transport 
1.1.3.1 Microtubule-based motor proteins – kinesin and dynein 
    The best-known motor proteins for long distance movement of mitochondria are the 
microtubule-based motor proteins, kinesin and dynein. Kinesin is responsible for 
anterograde transport, and dynein is responsible for retrograde transport (Pilling et al., 
2006; Saxton and Hollenbeck, 2012) (Fig. 1.1B, E).  
    Then main kinesin family that plays a key role in mitochondrial anterograde transport 
is the kinesin-1 family (also known as KIF5). In mammals, there are three isoforms of 
KIF5: KIF5A, KIF5B, and KIF5C. All of them have two kinesin heavy chains (KHCs) 





has a motor domain in the amino-terminal that binds to microtubules and moves toward 
the microtubule plus ends; in the carboxy-terminal, it contains a cargo-binding domain 
that is associated with KLCs to bind cargoes or adaptor proteins (Hirokawa et al., 2010). 
In mitochondrial axonal transport, mutations of khc (Drosophila KIF5 homologue) 
produce impaired mitochondrial transport (Pilling et al., 2006). This indicates that 
kinesin-1 is the primary mitochondrial motor for the anterograde direction. In addition to 
kinesin-1, KIF1B, one of the kinesin-3 family proteins, has been suggested to transport 
mitochondria based on an in vitro study (Nangaku et al., 1994). KLP6, a newly identified 
kinesin, may also regulate mitochondrial transport in neuronal cells (Tanaka et al., 2011).  
    Cytoplasmic dynein contains two dynein heavy chains (DHCs), several light chains 
(DLCs), light intermediate chains (DLICs), and intermediate chains (DICs). DHCs serve 
as motors in dynein. Other structures can interact with dynactin, a large complex 
regulating the interaction between cargoes, microtubules, and dynein, to transport cargoes 
(Hirokawa et al., 2010). In Drosophila, mutations of the dynein heavy chain (Dhc) 
produce reduced velocity and run length of retrograde mitochondrial transport (Pilling et 
al., 2006). Down-regulation of the dynactin subunit p150Glued also reduces mitochondrial 
transport (Pilling et al., 2006). These studies indicate that dynein is the primary motor for 
mitochondrial retrograde transport.  
    While kinesin and dynein have their dominant directions of movement, their actions 
can be interdependent. From genetic analysis in Drosophila, mutations of kinesin-1 
exhibit  genetic interactions with mutations of dynein and dynactin (Martin et al., 1999). 
Mutations of dynein inhibit retrograde mitochondrial transport, whereas mutations of 
kinesin-1 inhibit mitochondrial transport in both directions (Pilling et al., 2006), 
indicating there are some interactions between kinesin and dynein. Although Miro 
possibly interact with both kinesin and dynein (Russo et al., 2009) (More detailed in 
Section 1.1.3.4), how these proteins cooperate to control mitochondrial transport remains 
unclear. 
1.1.3.2 Actin-based motor protein – myosin 
    Since axons contain actin filaments with mixed polarity, and mitochondria have been 





1995; Bridgman, 2004; Saxton and Hollenbeck, 2012), raising the issue of a role for 
myosin in mitochondrial transport. In vertebrate neuronal cultures, disruption of actin 
filaments increases the velocity of mitochondrial transport (Morris and Hollenbeck, 
1995). In Drosophila neuronal cell culture, down-regulation of myosin V increases 
mitochondrial transport in both directions. Moreover, down-regulation of myosin VI also 
increases mitochondrial transport but only in the retrograde direction (Pathak et al., 2010). 
These suggest that myosin competes with microtubule-based motors and thereby supports 
mitochondria halting along the axon (Fig. 1.1D). 
1.1.3.3 Microtubule-based docking protein -- syntaphilin   
    Recently, Sheng’s group identified a new protein, syntaphilin, that can anchor 
mitochondria on microtubules (Kang et al., 2008; Chen et al., 2009; Chen and Sheng, 
2013) (Fig.1.1C). Syntaphilin was originally reported to regulate fusion or docking of 
synaptic vesicles by inhibiting SNARE (Soluble NSF Attachment Protein Receptor) 
formation (Lao et al., 2000). In its carboxyl-terminal domain, syntaphilin has the 
structure that target to mitochondrial outer membrane. It also contains the microtubule 
binding domain (Kang et al., 2008). In the stationary mitochondria population, most of 
mitochondria are co-localized with syntaphilin, whereas moving mitochondria are not.  
Syntaphilin-tagged mitochondria are highly correlated to the stationary mitochondria. 
When the syntaphilin gene (snph) is deleted, mitochondrial transport dramatically 
increases; overexpression of syntaphilin produces an almost immobilized population of 
mitochondria (Kang et al., 2008). Ca2+ can regulate the effects of syntaphilin on 
mitochondrial docking (Chen and Sheng, 2013). Interestingly, dynein light chain LC8 is 
shown to associate with syntaphilin, facilitating interactions between syntaphilin and 
microtubules (Chen et al., 2009).  However, syntaphilin only exists in mammals and is 
not found, for example, in Drosophilia genome. Yet Drosophila also shows a similar 
stationary population of mitochondria, suggesting that other mitochondrial-docking 
machineries may play an important role in stopping mitochondrial movement. Thus, the 





1.1.3.4 Motor adaptor proteins – Miro and Milton   
    Miro and Milton are two important adaptor proteins connecting mitochondria to the 
kinesin-1 motor for transport (Fig. 1.1 and 1.2A). Miro, a mitochondrial outer membrane 
Rho GTPase protein, was found and characterized in both humans and Drosophila 
(Fransson et al., 2003; Guo et al., 2005). Miro has two EF-hand Ca2+-binding motifs and 
GTPase domains. In a Drosophila genetic screen, mutations of Drosophila Miro impaired 
mitochondrial axonal transport to the synapses (Guo et al., 2005). Similarly, human Miro-
1 and Miro-2 are both essential for mitochondrial traffic in mammals (Fransson et al., 
2003; Fransson et al., 2006). Interestingly, mutations in Miro produce a reduction of 
mitochondrial transport both anterogradely and retrogradely, suggesting a possible 
interaction between Miro and both kinesin and dynein (Russo et al., 2009). This has not 
been explored. 
    Milton is a linker protein between mitochondria and kinesin, first identified from a 
Drosophila genetic screen (Stowers et al., 2002). In homozygous Milton mutants, 
mitochondria are rare in the terminals of photoreceptors, but are still present in the soma 
of these cells (Stowers et al., 2002; Górska-Andrzejak et al., 2003). This study suggests 
that Milton is involved in the mediation of mitochondrial transport. In addition, Milton 
has been shown to bind directly to the carboxyl-terminal region of KHCs and interacts 
with Miro, providing the evidence that Miro, Milton, and KHC form an essential protein 
complex for mitochondrial anterograde transport (Glater et al., 2006).  
    In mammals, two Milton orthologues TRAK1 and TRAK2 (also known as OIP106 and 
Grif1, respectively) have been identified and been shown as adaptor proteins physically 
binding to kinesin motors (Brickley et al., 2005; Smith et al., 2006). Evidence that 
mammalian TRAK family are involved in the regulation of mitochondrial transport are 
also provided. Elevated Miro 1 levels recruit TRAK2 to mitochondria and increase 
mitochondrial transport to the distal ends of neuronal process in hippocampal neurons 
(MacAskill et al., 2009). In addition, down-regulation of TRAK1 impair mitochondrial 
transport in axons (Brickley and Stephenson, 2011). 
    An overall picture of current model of the mitochondrial transport machinery is shown 





kinesin-1 using adaptor proteins Miro, Milton, or others (Fig. 1.1E). For retrograde 
transport, dynein is the primary motor (Fig. 1.1B). For stationary mitochondria, myosin 
may compete with kinesin or dynein to halt mitochondria (Fig. 1.1D). Syntaphilin is 
another docking protein in mammals (Fig. 1.1C). Other unknown regulating proteins or 
factors are also involved in this transport machinery.   
 
1.1.4 Regulation of mitochondrial transport 
1.1.4.1 Cytosolic Ca2+ in the regulation of mitochondrial transport 
    Ca2+ is one of the most-studied factors regulating mitochondrial transport. In cardiac 
myoblasts, elevated Ca2+ levels in the physiological range inhibit mitochondrial 
movement (Yi et al., 2004). In primary neuronal culture, synaptic activity or activation of 
the glutamate receptors increases Ca2+ and reduces mitochondrial transport (Rintoul et al., 
2003; Chang et al., 2006a). Furthermore, in myelinated nerves, increased Ca2+ levels 
caused by action potentials also reduce mitochondrial motility (Zhang et al., 2010; Ohno 
et al., 2011). These raise the question: what are the regulators and mechanisms for 
mitochondrial transport in response to Ca2+? To date, there are three groups proposing 
different models of the mechanisms by which mitochondrial halting occurs. (Macaskill et 
al., 2009; Wang and Schwarz, 2009; Chen and Sheng, 2013) (Fig. 1.2). 
    MacAskill et. al suggest that Miro is the Ca2+ sensor for mitochondrial transport and 
physically interacts with kinesin. When Ca2+ levels increase, Ca2+ binds to the EF motifs 
on Miro, and that releases the mitochondria-Miro-TRAK complex from kinesin. As a 
result, mitochondrial transport is inhibited (Macaskill et al., 2009) (Fig. 1.2A, B). Wang 
and Schwarz propose a similar mechanism. Miro physically binds to kinesin, and 
elevated Ca2+ levels inhibit mitochondrial transport. However, when Ca2+ levels increase, 
kinesin remains attached to the mitochondria-Miro-TRAK complex. Ca2+ binds to the EF-
domain of Miro and induces the attachment of the kinesin motor domain to Miro instead 
of microtubules, slacking the interaction between kinesin and microtubules (Wang and 
Schwarz, 2009) (Fig. 1.2C). A recent study from Chen and Sheng included another 
proposed model of mitochondrial transport inhibition. They suggest that elevated Ca2+ 





that syntaphilin competes with TRAK and inhibits kinesin motor ATPase activity, such 
that kinesin cannot move along microtubules. When Ca2+ levels increase, it favors the 
interaction between syntaphilin and kinesin instead of TRAK and kinesin. Thus, 
mitochondrial movement stops (Chen and Sheng, 2013) (Fig. 1.2D). Overall, although 
they propose different models, all groups indicate that Ca2+ binding to the EF-domain of 
Miro inhibits mitochondrial transport. 
1.1.4.2 Signaling pathways in the regulation of mitochondrial transport 
    Although Ca2+ is the most-studied regulator for mitochondrial transport, many 
signaling pathways have been shown to play roles in the regulation of general or 
mitochondrial transport in neurons. In axons, mitochondria are recruited in response to 
Nerve Growth Factor (NGF), and this recruitment is inhibited by the phosphoinositide 3-
kinase (PI3K) inhibitors, suggesting that the PI3K signaling pathway play a role in the 
regulation. (Chada and Hollenbeck, 2003, 2004).  
    In addition, Akt/Gsk3β signaling has been shown to mediate general or mitochondrial 
axonal transport. Glycogen synthase kinase 3 (Gsk3) can phosphorylate kinesin light 
chain, which reduces the binding affinity between kinesin-1 and its cargoes, thereby 
inhibiting axonal organelle transport (Morfini et al., 2002). Other studies show that 
Gsk3β can regulate mitochondrial transport, but the results are controversial. Inhibition of 
Gsk3β, whose activity is blocked by Akt-mediated phosphorylation, stimulates axonal 
mitochondrial transport (Chen et al., 2007). However, other studies show that 
overexpression of Gsk3β increases mitochondrial transport in both directions, but more 
robustly in the anterograde direction (Llorens-Martín et al., 2011; Ogawa et al., 2016). 
This regulation possibly depends on the microtubule associated proteins, Tau, that can be 
phosphorylated by GSK3 and regulate the bindings of motors to microtubules (Llorens-
Martín et al., 2011), or association with TRAK (Ogawa et al., 2016). 
    Another possible component is the C-Jun N-terminal Kinase (JNK) signaling pathway. 
Activation of JNK can phosphorylate kinesin heavy chain and reduce its interaction 
between kinesin and microtubules, thereby causing inhibition of axonal transport 





1.1.4.3 PINK1/Parkin in the regulation of mitochondrial transport 
    PINK1 and Parkin are two critical genes for a familial early-onset form of Parkinson’s 
disease (Kitada et al., 1998; Valente et al., 2004). PINK1 is PTEN-induced putative 
kinase 1 and Parkin is an E3 ubiquitin ligase. Both of them are important for 
mitochondrial function and in the same signaling pathway where Parkin is downstream of 
PINK1 (Greene et al., 2003; Clark et al., 2006; Park et al., 2006). In healthy mitochondria, 
PINK1 is imported through the translocases TIM (Translocase complex of inner 
membrane) and TOM (Translocase complex of outer membrane) and cleaved by 
mitochondrial-processing protease (MPP) and presenilin-associated rhomboid-like 
protease (PARL) (Meissner et al., 2011; Greene et al., 2012). However, when 
mitochondria are depolarized, PINK1 is stabilized on mitochondrial outer membrane, 
where it recruits Parkin and induces mitophagy (Narendra et al., 2008; Matsuda et al., 
2010; Narendra et al., 2010; Lazarou et al., 2012).   
    The first evidence relating PINK1/Parkin to mitochondrial transport is that PINK1 
forms a complex with Miro and Milton (Weihofen et al., 2009). Later, Wang et. al 
provided the evidence that PINK1 and Parkin are involved in the regulation of 
mitochondrial transport by inhibiting mitochondrial movement (Wang et al., 2011) (Fig. 
1.3). They showed that overexpression of PINK1 or Parkin inhibits mitochondrial 
movement in mammalian hippocampal and Drosophila CCAP neurons. In addition, 
knockdown of PINK1 or Parkin increases mitochondrial movement in Drosophila, 
suggesting that PINK1 and Parkin play a role in the regulation of mitochondrial transport. 
To induce the PINK1/Parkin pathway, cells are treated with carbonyl cyanide m-
chlorophenylhydrazone (CCCP). Under these conditions, PINK1 and Parkin are 
associated with Miro. In addition, PINK1 phosphorylates Miro, which induces 
degradation of Miro and results in the release of kinesin and Milton from mitochondria 
(Wang et al., 2011). Another group provide the evidence that Miro is the substrate of 
Parkin (Liu et al., 2012). Based on these results, Wang et al. proposes this model. When 
mitochondria are depolarized, they recruit PINK1, which phosphorylates Miro (Fig. 





ubiquitination (Fig. 1.3C). Ubiquitinated Miro is then degraded, so mitochondria release 
from microtubules and stop (Fig. 1.3D).  
    Although they proposed this model, a recent study shows the opposite results. 
Devireddy et al. examined mitochondrial transport, morphology, and membrane potential 
in PINK1 mutation in the Drosophila motor neurons. They shows that PINK1 null-
mutation inhibits mitochondrial transport by reducing flux in both directions and 
anterograde duty cycle, whereas overexpression of PINK1 increases retrograde moving 
mitochondria (Devireddy et al., 2015). Thus, it still remains unclear how PINK1/Parkin 
regulate mitochondrial transport. 
1.1.4.4 Interrelationship of mitochondrial metabolic state, fission-fusion dynamics, and 
transport 
    Since motor proteins require ATP for their activity, mitochondrial metabolic state 
might be associated with mitochondrial transport. In mammalian primary neurons, cells 
treated by ATPase blocker oligomycin or by an uncoupler (FCCP or CCCP), which 
inhibits mitochondrial electron transport, show a decrease in mitochondrial transport 
(Rintoul et al., 2003; Miller and Sheetz, 2004). However, treatment with antimycin, an 
inhibitor of mitochondrial complex III, increases mitochondrial transport (Miller and 
Sheetz, 2004). These results suggest that there might be some connections between 
mitochondrial metabolic state and transport. However, it remains controversial whether 
mitochondrial membrane potential is different between axonal mitochondria moving in 
different directions (Miller and Sheetz, 2004; Verburg and Hollenbeck, 2008).  Miller 
and Sheetz suggest that mitochondria with high membrane potential preferentially move 
anterogradely, and mitochondria with low membrane potential move retrogradely (Miller 
and Sheetz, 2004). Whereas Verburg and Hollenbeck provide the evidence that 
anterograde, retrograde, and stationary mitochondria shows no different in mitochondrial 
membrane potential (Verburg and Hollenbeck, 2008). 
    In addition to metabolic state, numerous studies provide evidence that mitochondrial 
fission-fusion dynamics are highly interrelated with mitochondrial transport (Rintoul et 
al., 2003; Verstreken et al., 2005; Fransson et al., 2006; Baloh et al., 2007; Saotome et al., 






treated with glutamate show both reduced mitochondrial movement and mitochondrial 
length (Rintoul et al., 2003). Overexpression of motor adaptor protein Miro induces 
mitochondrial fusion (Fransson et al., 2006; Saotome et al., 2008). Knockdown of 
Myosin V, the motor protein for halting mitochondrial transport, increases mitochondrial 
length (Pathak et al., 2010) 
    This connection between fission-fusion and transport might involve mitochondrial 
fission or fusion proteins, including Drp1 (Dynamin related protein 1), mitofusin 2, or 
Opa1 (Optic atrophy protein 1) (Verstreken et al., 2005; Baloh et al., 2007; Misko et al., 
2010; Yu et al., 2016). In a forward screen in Drosophila, mutations of Drp1, one of the 
mitochondrial fission protein, were found to reduce the number of mitochondria in 
synaptic terminals (Verstreken et al., 2005). Mitofusin 2, a mitochondrial outer 
membrane fusion protein, also interacts with Miro/Milton complex and is required for 
mitochondrial transport (Baloh et al., 2007; Misko et al., 2010). Knockdown of 
Drosophila Opa1, a mitochondrial inner membrane fusion protein, recently has been 
shown to reduce mitochondrial transport in the third instar larval neurons (Yu et al., 
2016), whereas Opa1 has no effect in dorsal root ganglion (DRG) cultures (Misko et al., 
2010). 
    Overall, although the detailed mechanisms remain unclear, these studies indicate that 
mitochondrial metabolic state, fission-fusion dynamics, and transport are highly 
interrelated. 
 
1.1.5 Mitochondrial transport and neurodegenerative diseases 
    Since mitochondrial transport is important for neuronal survival, it is not surprising 
that defects in mitochondrial transport are associated with a variety of neurodegenerative 
diseases.  
    Alzheimer’s disease is involved in progressive dementia. Two pathological hallmarks 
in Alzheimer’s disease are neuritic plaques containing Amyloid-β aggregates and 
neurofibrillary tangles containing hyperphosphorylated Tau proteins. It has been shown 
that a short period of exposure of cultured hippocampal neurons to Amyloid-β impairs 






mitochondrial transport can be rescued by the reduction of another key pathogenic factor, 
Tau (Vossel et al., 2010). In addition to Alzheimer’s disease, recent studies also provided 
evidence that factors inducing Parkinson’s disease are associated with impaired 
mitochondrial transport (Kim-Han et al., 2011; Devireddy et al., 2015). Environmental 
toxin inducing Parkinson’s disease, 1-methyl-4-phenylpyridinium ion (MPP+), 
specifically induces defects of mitochondrial transport in dopamine axons (Kim-Han et 
al., 2011).  Mutant PINK1, one of the pathogenic factor inducing familial early-onset 
Parkinson’s disease, also impairs mitochondrial transport by reducing flux and duty cycle 
(Devireddy et al., 2015). 
    Other neurodegenerative diseases are also associated with impaired mitochondrial 
transport. For example, mutations of superoxide dismutase 1 (SOD1) that induce 
amyotrophic lateral sclerosis (ALS)  also produce a decrease in mitochondrial transport 
(De Vos et al., 2007; Magrané et al., 2009; Magrané et al., 2012; Song et al., 2012). 
Mutations of huntingtin, which is associated to Huntington’s disease, can induce defects 
in mitochondrial transport, and evidence suggests that this is possibly caused by the 
interaction between the amino-terminal of mutant huntingtin and mitochondria (Chang et 
al., 2006b; Orr et al., 2008). In addition, pathogenic huntingtin inhibits axonal transport 
by the activation of JNK3 and resulting phosphorylation of kinesin (Morfini et al., 2009). 
Thus, these studies provide strong evidence that impaired mitochondrial transport is one 








Figure 1.1. Mitochondrial transport in axons. A, The simplified representation of a 
neuronal cell contains a cell body, dendrites, an axon, and a synaptic terminal. 
Mitochondria transport from the cell body to the synaptic terminal (anterograde transport) 
or from the terminal to cell body (retrograde transport). Some mitochondria stay 
stationary. B – E, Representations of anterograde, retrograde, and stationary 
mitochondria. Dynein and kinesin are the primary motors for retrograde and anterograde 
transport of mitochondria, respectively (B, E). These motors need adaptor proteins to 
bind mitochondria. Syntaphilin is the docking protein for stationary mitochondria in 
mammalian neurons (C). Myosin can compete microtubule-based motors (kinesin or 










Figure 1.2. Models of Ca2+ regulation in mitochondrial transport. A, Miro is the 
mitochondrial outer membrane protein and has two Ca2+ binding EF-hand motifs. In the 
anterograde moving mitochondria, Miro and the adaptor protein Milton form the complex. 
This Miro-Milton complex interacts with kinesin and drives mitochondrial transport 
anterogradely. B, In the first model, Ca2+ binds to Miro and that releases kinesin from 
mitochondria when Ca2+ levels increase. Thus, mitochondrial transport is reduced  
(Macaskill et al., 2009). C, In the second model, Ca2+ binding releases the kinesin motor 
domain from microtubules and induces bindings between the motor domain and Miro 
(Wang and Schwarz, 2009). D, Syntaphilin is involved in the Ca2+ regulation of 
mitochondrial transport. Elevated Ca2+ levels switch kinesin binding from Miro-Milton 
complex to the docking protein, synatphilin. Syntaphilin can inhibit the activity of kinesin 














Figure 1.3. Recent model of PINK1/Parkin regulation in mitochondrial transport. A, 
Healthy mitochondria move anterogradely via Miro-Milton-kinesin machinery. B, 
Unhealthy or depolarized mitochondria recruit PINK1, which phosphorylates Miro. C, 
PINK1-phosphorylated Miro may recruit Parkin, which induces Miro ubiquitination. D, 

















1.2 Reactive oxygen species (ROS) 
 
1.2.1 Reactive oxygen species (ROS) and antioxidants 
    Reactive oxygen species (ROS) are the partially reduced forms of oxygen, which are 
highly reactive due to their unstable free radicals. There are several varieties of ROS. 
When oxygen is one-electron reduced, it converts to the superoxide anion (O2-·). Two-
electron reduction leads to hydrogen peroxide (H2O2) formation. A further one-electron 
reduction of hydrogen peroxide forms the highly reactive hydroxyl radical (OH·) 
(Brookes et al., 2004; Son et al., 2013; Lambeth and Neish, 2014) (Fig. 1.4). These ROS 
are harmful for cells because they damage macromolecules or subcellular structures such 
as proteins, lipids, and DNA (Brookes et al., 2004; D'Autréaux and Toledano, 2007; Son 
et al., 2013). Although these ROS are highly reactive and potentially destructive, cells 
use their antioxidant systems to control their levels and maintain the ROS balance. 
    These antioxidant systems include several antioxidant enzymes as well as non-
enzymatic antioxidants (Fig. 1.4). Among antioxidant enzymes, superoxide dismutase 
(SOD) converts superoxide to hydrogen peroxide. There are three different isoforms of 
SOD: SOD1, copper-zinc superoxide dismutase (Cu/Zn SOD), is expressed mostly in the 
cytosol. SOD2, manganese superoxide dismutase (Mn SOD), is expressed primarily in 
mitochondria. SOD3, extracellular superoxide dismutase (EC SOD), is secreted into the 
extracellular space (Mruk et al., 2002). Catalase or glutathione peroxidase (GSH Px) 
reduces hydrogen peroxide to water (H2O). Catalase mostly resides in peroxisomes, but 
also exists in the cytoplasm and in mitochondria. Glutathione peroxidase reduces 
hydrogen peroxide to water using reduced glutathione (GSH) as an electron donor, and 
these glutathione then forms disulfide bonds (Gandhi and Abramov, 2012). In addition to 
antioxidant enzymes, there are several non-enzymatic antioxidants, including glutathione, 
vitamin C and E, thioredoxin (Trx), and others (Gandhi and Abramov, 2012; Son et al., 
2013). These non-enzymatic antioxidants also play important roles in the regulation of 
redox balance. 
    If the balance of ROS and antioxidants is disrupted, excess ROS production can induce 






different neurodegenerative diseases and to activate a variety of signaling pathways 
(Shen and Liu, 2006; Court and Coleman, 2012; Federico et al., 2012; Fischer et al., 2012; 
Son et al., 2013; Bhat et al., 2015), as described below.   
 
1.2.2 Major sources of ROS 
1.2.2.1 Mitochondria 
    Mitochondria are one of the major sources of ROS in the cell. In the mitochondrial 
inner membrane, the electron transport chain is one of the important functional parts of 
ATP generation, but also is the location of ROS production. ROS are generated in 
different sites in the electron transport chain, primarily at complex I (NADH-ubiquinone 
oxidoreductase) and III (ubiquinone-cytochrome c reductase) (Brookes et al., 2004; Bhat 
et al., 2015; Genova and Lenaz, 2015).  
    Complex I generates ROS via its iron-sulfur clusters (Genova et al., 2001). These ROS 
are produced during forward electron transfer in the electron transport chain and stay in 
the matrix. (Genova et al., 2001; Genova and Lenaz, 2015). ROS formation from 
complex III depends on the Q-cycle in electron transfer. In the Q-cycle, the 
ubisemiquinone (QH·) intermediate which normally reduces low-potential cytochrome b 
(cyt bL), instead interacts with oxygen and generates superoxide (Brookes et al., 2004; 
Genova and Lenaz, 2015). ROS generated by complex III are released into the 
intermembrane space and can be exported to the cytoplasm via the voltage dependent 
anion channels (VDACs) (Han et al., 2003). In addition to complex I and III, complex II 
(succinate dehydrogenase) has been suggested to be involved in the generation of ROS 
by electron transfer back to complex I (Brookes et al., 2004; Genova and Lenaz, 2015). 
Other enzymes of oxidative phosphorylation (OXPHO) are also involved in the ROS 
generation, in less defined ways. 
    Although mitochondria generate significant ROS, they also have some self-defense 
systems to prevent damage from oxidative stress. For example, in the matrix, 
mitochondria have Mn-SOD (SOD2) that converts superoxide to H2O2 (Son et al., 2013). 






superoxide from the matrix to the cytoplasm (Han et al., 2003; Wojtczak et al., 2011), 
thereby preventing the toxic superoxide accumulation within mitochondria. 
1.2.2.2 NADPH oxidase (Nox) family 
    The NADPH oxidase (Nox) family comprises a group of enzymes that depend on 
NADPH to reduce oxygen and generate superoxide or hydrogen peroxide. To date, there 
are seven enzymes known in mammals, including five Nox isoforms (Nox1, Nox2, Nox3, 
Nox4, and Nox5) and two related enzymes, Duox (Dual oxidase) 1 and Duox 2 (Aguirre 
and Lambeth, 2010; Katsuyama et al., 2012; Lambeth and Neish, 2014).  
    Nox2, before called gp91phox, was the first identified Nox enzyme (Royer-Pokora et al., 
1986). Activation of Nox2 oxidase requires the assembly of Nox2 and other regulatory 
factors including p22phox, p47phox, p40phox, p67phox, and a small GTP-binding protein, Rac. 
Nox1, 3, and 4 also need p22phox. Nox 1 and 3 need additional regulatory subunits 
NOXO1 (Nox organizer 1) and NOXA1 (Nox activator 1), but Nox4 is constitutively 
active. Nox5, Duox1, and Duox2 are p22phox independent. These three proteins have EF 
hand Ca2+ binding domains and are activated by Ca2+. In addition to EF hand Ca2+ 
binding domains, Duox 1 and 2 contain peroxidase-homology domains and also form 
complexes with Duox accessory proteins, DuoxA1 and A2, repectively, to localize on the 
membrane (Aguirre and Lambeth, 2010; Katsuyama et al., 2012; Lambeth and Neish, 
2014). The primary species of ROS generated by Nox1, 2, 3, and 5 are superoxide, 
whereas Nox4, Duox1 and 2 usually produce hydrogen peroxide. 
    These Nox proteins are involved in the regulation of varied biological processes in 
mammals. For example, they play physiological roles in growth, development, cell 
motility, muscle contraction, cytoskeleton reorganization, cell survival/apoptosis, stress 
adaption, and inflammation (Lambeth and Neish, 2014).  In the nervous system, Nox 
enzymes are expressed in neurons, microglia, astrocytes, and neuromuscular junctions. 
There, they play roles in neural development, neural stem cell biology, and overall neural 
function (Nayernia et al., 2014).   
    In Drosophila, there are just two Nox enzymes. dNox (Drosophila Nox) is the 
homologue  of mammalian Nox5, containing EF-hand Ca2+ binding domains. dDuox 






binding domains and peroxidase-homology domains (Ha et al., 2005). These Nox 
enzymes are expressed primarily in gut but also in the central nerve system, at lower 
levels (Flybase). dNox has been shown to regulate smooth muscle contraction (Ritsick et 
al., 2007). In addition, symbiotic lactobacilli can stimulate gut epithelial proliferation via 
dNox (Jones et al., 2013). dDuox are involved in gut immunity, which is induced by 
bacterial-derived uracil (Ha et al., 2005; Lee et al., 2013). dDuox also regulate the wound 
immunity response and stabilize the cuticle structure of the adult wing (Anh et al., 2011; 
Razzell et al., 2013). 
    Thus, ROS are not only toxic for cells, but also play important roles in many biological 
processes under physiological conditions.  
 
1.2.3 ROS and transport-related cell signaling 
    Since ROS have highly reactivity and oxidize other molecules such as proteins, it is 
unsurprising that they have roles in the modulation of signaling pathways. One of the 
main amino acid residues that can be oxidized is the cysteine residue. When ROS oxidize 
cysteine residues and lead the formation of disulfide bond (-SH  -S-S-), it changes 
protein activity and/or conformation (Son et al., 2013; Genova and Lenaz, 2015). Among 
these ROS-induced signaling pathways, I will focus on two pathways related to axonal 
transport (Section 1.1.4.2, above). 
1.2.3.1 JNK signaling pathway    
    c-Jnu N-terminal kinase (JNK), also called stress-activated protein kinase, is one of the 
subgroups of the mitogen-activated protein kinase (MAPK) family. In mammals, there 
are three isoforms: JNK-1, JNK-2, and JNK-3. JNK-1 and JNK-2 are expressed 
ubiquitously, but JNK-3 is expressed mainly in neuronal tissue (Shen and Liu, 2006; Son 
et al., 2013).  
    Like other MAPK family members, JNK is regulated by MAP kinase kinase kinase 
(MAPKKK) and MAP kinase kinase (MAPKK). Two MAPKK family members, MKK4 
and MKK7 (known as JNKK1/MEK4 and JNKK2/MEK7, repectively) phosphorylate 
and activate JNK. MKKs are phosphorylated by numerous MAPKKK, including MEK 






(MLK), and transforming growth factor-β (TGFβ) activated kinase (TAK). (Shen and Liu, 
2006; Son et al., 2013). Downstream targets of JNK include members of the transcription 
factor AP-1 familiy (for example, c-Jun), p53, and c-Myc (Shen and Liu, 2006). 
    In Drosophila, there are one JNK (Basket, Bsk) and two JNKKs (Hemipterous, Hep, a 
MKK7 homologue, and dMKK4). These Drosophila JNKKs are also activated by 
different MAPKKKs similar to mammals. One of the important downstream genes in the 
AP-1 family is puckered (puc), which encodes a JNK-specific phosphatase that inhibits 
JNK activity  (Biteau et al., 2011).      
    What are the mechanisms involved in the activation of the JNK pathway by ROS? 
ASK1 plays the major role in this regulation. ASK1 has been shown to be a specific 
target of ROS since its activation is mediated by two redox-sensitive proteins, 
thioredoxin and glutaredoxin (Gotoh and Cooper, 1998; Saitoh et al., 1998; Tobiume et 
al., 2001; Song et al., 2002; Song and Lee, 2003). The reduced form of thioredoxin or 
glutaredoxin binds to ASK1 and inhibits ASK1 activity. In the presence of ROS, 
thioredoxin and glutaredoxin are oxidized and released from ASK1, thereby enhancing 
ASK1 activity (Gotoh and Cooper, 1998; Saitoh et al., 1998; Tobiume et al., 2001; Song 
et al., 2002; Song and Lee, 2003). Activated ASK1 then initiates the activation of the 
ASK1-JNKK-JNK signaling pathway and the expression of the downstream genes (Shen 
and Liu, 2006; Biteau et al., 2011; Son et al., 2013) (Fig. 1.5A). 
1.2.3.2 PI3K/Akt/GSK3β signaling pathway 
    The PI3K/Akt signaling pathway is involved in many cellular functions including 
protein synthesis, cell cycle, proliferation, and apoptosis in response to growth factors 
(Clerkin et al., 2008; Zhang et al., 2016). When growth factors bind and activate receptor 
tyrosine kinase (RTK), it recruits phosphoinositide-3-kinase (PI3K). After PI3K is 
recruited, PI3K phosphorylates phosphatidylinositol 4,5-biphosphate (PIP2) to form  
phosphatidylinositol 3,4,5-biphosphate (PIP3). PIP3 recruits proteins containing 
pleckstrin homology (PH) domains, such as phophoinositide-dependent protein kinase 
(PDK) and protein kinase B (PKB/Akt). These proteins, PDK and Akt, are 






example, GSK3, FOXO, p53, Bad, and mTOR) (Clerkin et al., 2008; Sullivan and 
Chandel, 2014; Zhang et al., 2016) (Fig. 1.5B). 
    One of the downstream targets is glycogen synthase kinase 3β (GSK3β), a member of 
a family of conserved serine/threonine kinases (Hardt and Sadoshima, 2002). GSK3β was 
originally named because of its function of phosphorylation of glycogen synthase and 
inhibition of glycogen synthesis, but now it has been shown involved in varied cellular 
functions (Cohen and Frame, 2001; Hardt and Sadoshima, 2002). GSK3β is the negative 
regulator of its downstream targets. Without phosphorylation, GSK3β is active, but 
downstream targets are less active. Once GSK3β is phosphorylated, it becomes 
inactivated, and thus its downstream targets are active. Thus, activation of PI3K/Akt 
stimulates downstream targets via inhibition of GSK3β activity (Cohen and Frame, 2001; 
Hardt and Sadoshima, 2002) (Fig. 1.5B). 
    How is the PI3K/Akt/GSK3β pathway activated by ROS? Since PI3K/Akt/GSK3β is 
activated by phosphorylation, this pathway is negatively regulated by phosphatases 
(Clerkin et al., 2008; Zhang et al., 2016). One of the well-studied phosphatases, 
Phosphatase and Tensin homologue (PTEN), can dephosphorylate PIP3 to PIP2 and 
inhibit the PI3K/Akt/GSK3β pathway. PTEN has cysteine residues in the active site. In 
the presence of ROS, these cysteine residues are oxidized to form disulfide bonds, 
thereby inactivating PTEN. Inactivated PTEN loses the ability to dephosphorylate PIP3 
to PIP2, and thereby activates the PI3K/Akt/GSK3β pathway (Clerkin et al., 2008; Zhang 
et al., 2016) (Fig. 1.5B). 
 
1.2.4 ROS and Ca2+ homeostasis 
    Ca2+ is an important second messenger regulating numerous cellular functions such as 
muscle contraction, gene expression, cell survival and cell death (Berridge, 2012). Ca2+ 
can either flow into the cytoplasm through Ca2+ channels or be pumped out of the 
cytoplasm by Ca2+ pumps in the plasma membrane or endoplasmic reticulum (ER). Most 
of these Ca2+ channels and pumps have cysteine residues that are sensitive to redox status 






mediate Ca2+ homeostasis. Here I focus on how ROS mediate Ca2+ homeostasis via these 
channels and pumps. 
1.2.4.1 Effects of ROS on plasma membrane Ca2+ channels and pumps 
    Ca2+ enters cells through numerous Ca2+ channels, including voltage-dependent Ca2+ 
channels (VDCC), and receptor-coupled channels, among these are transient receptor 
potential (TRP) channels and the store-operated Ca2+ channels (SOC) mediated by Orai 
channel proteins (Görlach et al., 2015).  
    VDCCs can be oxidized by ROS because of the cysteine residues in their pore forming 
α1 subunits (Hudasek et al., 2004). Depending on the channel type, ROS can either 
induce or suppress Ca2+ influx via VDCCs (Görlach et al., 2015). For example, ROS 
suppress Ca2+ influx in guinea pig ventricular myocytes (Gill et al., 1995), whereas they 
stimulate Ca2+ influx through L-type and T-type VDCCs in smooth muscle cells (Tabet et 
al., 2004). 
    TRP channels are a group of Ca2+-permeable cation channels divided into six 
subfamilies. They are highly expressed in sensory receptor cells, and important for senses 
such as touch, taste, and smell (Voets et al., 2005). In this TRP family, some members 
have been shown to be sensitive to redox status (Takahashi and Mori, 2011; Görlach et 
al., 2015). TRPM2 was the first channel identified for its ROS-sensitivity. H2O2 has been 
shown to activate TRPM2 via the induction of nicotinamide adenine dinucleotide (β-
NAD+), which directly interacts with TRPM2 (Hara et al., 2002). In addition to TRPM2, 
some members, including TRPC5, TRV1, TRPA1, are directly mediated by ROS, NO, or 
oxidants via their cysteine residues (Yoshida et al., 2006; Xu et al., 2008; Görlach et al., 
2015).  
    Store-operated Ca2+ entry (SOCE) is the mechanism by which Ca2+ depletion of the ER 
lumen induces Ca2+ influx by activating Ca2+-permeable channels on the plasma 
membrane (Shen et al., 2011). When Ca2+ is depleted in the ER, an ER Ca2+ sensor, 
STIMs (stromal interaction molecules) move near the plasma membrane and activate 
Orai Ca2+ channels on the membrane, thereby inducing Ca2+ influx (Shen et al., 2011). 






However, other groups have suggested that ROS inhibit Orai via their cysteine residues 
and reduce Ca2+ influx (Bogeski et al., 2010; Bogeski et al., 2012). 
    The plasma membrane Ca2+ pump, or plasma membrane Ca2+-ATPase (PMCA), is 
important for maintaining resting cytoplasmic free Ca2+ concentration, and requires ATP 
hydrolysis to actively transport Ca2+. PMCA is activated by the dissociation of its 
autoinhibitory domain through the binding of calmodulin (CaM) and PMCA (Hidalgo 
and Donoso, 2008). While it remains unclear which residues are sensitive to redox, both 
PMCA and CaM have been shown to be sensitive to ROS, which inhibits PMCA activity 
(Hidalgo and Donoso, 2008; Zaidi, 2010; Görlach et al., 2015). 
1.2.4.2 Effects of ROS on intracellular Ca2+ channels and pumps 
    Intracellular Ca2+ is released from sarcoplasmic/endoplasmic reticulum (SR/ER) 
through two main Ca2+ channels: ryanodine receptors (RyR) in excitable cells; and 
inositol 1,4,5-trisphosphate receptors (IP3R) in non-excitable cells (Görlach et al., 2015). 
    RyR channels play important roles in cellular functions, including muscle contraction, 
synaptic activity, secretion, and cell death (Hidalgo and Donoso, 2008). They form 
homotetramers in the SR and ER membrane and contain numerous cysteine residues, 
rendering them sensitive to redox status (Hidalgo and Donoso, 2008; Görlach et al., 
2015). Oxidation of RyR has been shown to enhance RyR activity and thereby increase 
cytoplasmic Ca2+ levels (Hidalgo and Donoso, 2008; Görlach et al., 2015). For example, 
oxidation of RyR thiols increases SR Ca2+ leakage (Terentyev et al., 2008) and spark 
frequency (Yan et al., 2008).  
    IP3Rs are important for the regulation of development and fertilization mainly in the 
non-excitable cells, but also contribute to in cardiac and neuronal cells (Hidalgo and 
Donoso, 2008; Görlach et al., 2015). They are localized in the ER, and are activated by 
the binding of the ligand, inositol 1,4,5-triphosphate (IP3). When the IP3 binds to the 
IP3R, these channels open and release Ca2+ from the ER to the cytoplasm (Hidalgo and 
Donoso, 2008; Görlach et al., 2015). Several oxidants have been shown to activate IP3Rs 
by increasing the sensitivity of receptors to the ligands. For example, thimerosal oxidizes 
cysteine residues and stabilizes the active form of the IP3Rs (Bootman et al., 1992; Khan, 






intracellular Ca2+ levels (Lock et al., 2011). Thus, IP3Rs can be activated even IP3 levels 
are low. 
    The primary intracellular Ca2+ pumps are the sarcoplasmic/endoplasmic reticulum Ca2+ 
ATPase (SERCA). SERCA contains many cysteine residues (from 22 to 28 cysteines, 
depending on different isoforms), so it is sensitive to redox (Hidalgo and Donoso, 2008; 
Görlach et al., 2015). Several studies indicate that ROS inhibit SERCA activity via 
cysteine or tyrosine residues (Xu et al., 1997; Barnes et al., 2000; Brookes et al., 2004). 
In addition, since SERCA pumps require ATP for their activity, it is notable that ROS-
oxidized SERCAs reduce their ability to bind ATP and thus lose activity (Sharov et al., 
2006; Cook et al., 2012). Thus, in the presence of ROS, active Ca2+ transport by SERCAs 
is inhibited. 
 
1.2.5 ROS and neurodegenerative diseases 
    ROS have been shown to be associated with several neurodegenerative diseases. Most 
studies and reviews in this area focus on Alzheimer’s disease and Parkinson’s disease 
(Zhao and Zhao, 2013; Bhat et al., 2015; Blesa et al., 2015; Kim et al., 2015).  
    As mentioned in section 1.1.5, neuritic plaques containing Amyloid-β aggregates and 
neurofibrillary tangles containing hyperphosphorylated Tau proteins are two pathological 
hallmarks of Alzheimer’s disease. Amyloid-β has been shown to increase H2O2 levels 
(Behl et al., 1994). In transgenic mouse models with overexpression of mutant amyloid 
precursor protein (APP), accumulated Amyloid-β evokes oxidative stress (Smith et al., 
1998; Matsuoka et al., 2001). On the other hand, oxidative stress apparently increases the 
production of Amyloid-β oligomerization or plaque. In the transgenic mouse models, 
deletion of antioxidant enzymes, SOD1 or 2, increases Amyloid-β oligomerization or 
plaque formation (Li et al., 2004; Murakami et al., 2011), and overexpression of SOD2 
reduces oxidative stress and also decreases Amyloid-β plaque (Dumont et al., 2009). In 
addition to Amyloid-β, tau proteins are associated with oxidative stress. Tau has been 
shown to both block vesicle traffic and to enhance oxidative stress (Stamer et al., 2002), 






(Dias-Santagata et al., 2007). Overall, these studies provide evidence that oxidative stress 
is highly interrelated with Alzheimer’s disease.  
    Parkinson’s disease is characterized by the selective loss of dopaminergic (DA) 
neurons in the substantia nigra pars compacta (SNpc). One class of factors inducing 
Parkinson’s disease is environmental toxins. Some toxins, such as MPTP (or its 
derivative MPP+) and rotenone that are the inhibitors of mitochondrial complex I, are 
preferentially toxic to the DA neurons (Blesa and Przedborski, 2014). They inhibit the 
normal activity of complex I, disrupt the electron transport chain, and produce ROS 
mainly in the DA neurons, thereby inducing Parkinson’s disease (Mizuno et al., 1987; 
Betarbet et al., 2000). Paraquat is also preferentially toxic to DA neurons by activating 
NOX in microglia cells. In both in vitro and in vivo systems, paraquat neurotoxic actions 
to DA neurons in microglia cells is inhibited if NOX is deficient (Wu et al., 2005; Purisai 
et al., 2007). The pathological hallmark of both familial and sporadic Parkinson’s disease 
is the accumulation of the protein α-synuclein. It has been shown that this accumulation 
increases oxidative stress in DA neurons (Martin et al., 2006). Furthermore, oxidative 
stress also induces accumulation and oligomerization of α-synuclein in oligodendrocytes 
or brain slice cultures (Xu et al., 2013; Pukass and Richter-Landsberg, 2014), suggesting 
that oxidative stress and Parkinson’s disease are highly associated in a feed-forward 
manner. Mutations linked to the familial Parkinson’s disease are also linked to ROS. For 
example, PINK1 mutations have been shown to induce abnormal mitochondrial 
morphology and enhance vulnerability to ROS (Clark et al., 2006; Gautier et al., 2008), 
and that is rescued by downstream Parkin expression (Yang et al., 2006; Exner et al., 
2007).  
    Overall these numerous studies show that one of the factors inducing 
neurodegenerative disease is ROS, while the detailed mechanism remains unclear. Thus, 
it is important to find the fundamental connections between these two. 
 
1.2.6 ROS and mitochondrial axonal transport 
    As mentioned above (Sections 1.1.5 and 1.2.5), ROS and impaired axonal transport of 






clear whether or how ROS directly affect mitochondrial transport. Recent studies have 
shown that the H2O2 donor, tert-butyl hydroperoxide, or H2O2 treatment itself in cell 
culture systems leads to the reduction of organelle transport (Isonaka et al., 2011; Fang et 
al., 2012). In addition, an SOD1 mutant has been shown to reduce mitochondrial 
transport in vitro (Song et al., 2012). Whether these effects occur in the more complex, 
homeostatic, and normoxic in vivo environment remains unknown. Moreover, the 
mechanisms involved in the regulation of mitochondrial transport in the presence of ROS 
are still unclear.  
    Thus, in this study I used primary Drosophila neuronal cell culture and the third instar 
larval nervous system as in vitro and in vivo models, respectively, to elucidate the 
























Figure 1.4. ROS and antioxidant systems. When oxygen is one-electron reduced, 
oxygen converts to superoxide anion (O2-·). Two-electron reduction leads to hydrogen 
peroxide (H2O2) formation. A further one-electron reduction of hydrogen peroxide forms 
the highly reactive hydroxyl radical (OH·). Cells have antioxidant enzymes. SOD 
converts O2-· to H2O2; CAT and GSH Px convert H2O2 to H2O. Other antioxidants (some 











Figure 1.5 ROS regulation of the JNK and the PI3K/Akt/GSK3β pathway. A, ROS 
oxidize the cysteine residues of Trx or Grx, which activates ASK1 because of the 
dissociation of Trx or Grx. Activated ASK1 then phosphorylates downstream proteins 
and thereby activates the JNK pathway. B, ROS activate the PI3K/Akt/GSK3β pathway 
via the inhibition of the phosphatase PTEN. GSK3 is the negative regulator of the 
downstream targets. Activation of the Akt phosphorylates and inhibits GSK3 activity, 







CHAPTER 2.  MATERIALS AND METHODS 
2.1 Materials and chemicals 
 
2.1.1 Materials for in vivo studies 
    Dissecting microscope (Nikon SMZ645), Scissors (Fine Science Tools- FST # 15000-
00 straight), two pairs of forceps (FST, Dumont #5 Dumonstar # 11295-00), Sylgard 
plate (Sylgard 182 Silicone Elastomer Kit), Minutien insect pins (FST # 26002-10), glass 
slides (Rite-On microslides Cat # 3050, size 25mm X 75mm), coverslips (24 X 40 mm 
No.1, VWR Cat #16004-306) , double sided permanent tape (Scotch Cat # 137DM-2 or 
3M with 0.5 inch thickness), VALAP (Vaseline, Lanolin and Paraffin wax in equal parts) 
heated to 75°C, and small art paint brush. 
 
2.1.2 Materials for in vitro studies 
    Dissecting microscope (ZEISS STEMI SR), two pairs of forceps (FST, Dumont #5 
Dumonstar # 11295-00), Sylgard plate (Sylgard 182 Silicone Elastomer Kit), glass slides 
(Rite-On microslides Cat # 3050, size 25mm X 75mm), coverslips (VWR micro cover 
glass), double sided permanent tape (Scotch Cat # 137DM-2 or 3M with 0.5 inch 
thickness), VALAP (Vaseline, Lanolin and Paraffin wax in equal parts) heated to 75°C, 
and small paint brush. 
 
2.1.3 Chemicals for in vivo studies 
    HL6 buffer (Hemolymph-Like buffer): 23.7 mM NaCl (Mallinckrodt chemicals), 24.8 
mM KCl (Sigma), 15 mM MgCl2·6H2O (Mallinckrodt chemicals), 10 mM NaHCO3 
(Sigma), 20 mM Isothionic acid sodium salt (Sigma), 5 mM BES (Sigma), 80 mM 






 monohydrochloride (Sigma), 14.5 mM Glycine (Sigma), 11 mM L-Histidine (Sigma), 
1.7 mM L-Methionine (Sigma), 13 mM L-Proline (Sigma), 2.3 mM L-Serine (Sigma), 
2.5 mM L-Threonine (Sigma), 1.4mM L-Tyrosine (Sigma), 1 mM L-Valine (Sigma), 0.6 
mM CaCl2 Dihydrate (Sigma;), 4 mM L-Glutamate monosodium salt hydrate (Sigma)  
    Paraquat (Sigma) 
 
2.1.4 Chemicals for in vitro studies 
    Schneider’s medium (Gibco), 10% heat-inactivated Fetal bovine serum (FBS, Atlanta 
Biologicals),  Pen-Strep (50 U/mL penicillin with 50 μg/mL streptomycin, Gibco), 
collagenase (Sigma), concanavalin A (Sigma), tetramethylrhodamine methyl ester 
(TMRM, Life Technologies, Molecular Probes) , hydrogen peroxide 30% solution (H2O2, 
Macron Fine Chemicals), ethylene glycol tetraacetic acid (EGTA, Sigma), BAPTA-AM 
(Sigma) 
    Ca2+/Mg2+ free saline: 137 mM NaCl, 2.7 mM KCl, 0.36 mM NaH2PO4·H2O, 11.9 
mM NaHCO3, 5.6 mM glucose  
    S2 saline: 120 mM NaCl, 5 mM KCl, 8 mM MgCl2, 2 mM CaCl2, 10 mM HEPES 
 
2.2 Drosophila lines and maintenance 
    All Drosophila Stocks were maintained on normal fly food at 25°C with 40%-60% 
humidity and a 12 hr light/dark cycle. Fly genotypes used in this study are shown in the 











Table 2.1 Genotypes of flies in this study 
Number Fly genotypes Source 
1 +; D42-Gal4, UAS-mitoGFP Leo J. Pallanck (University 
of Washington) 
2 sp/Cyo; D42-Gal4, UAS-ANF-GFP William M. Saxton (UC 
Santa Cruz) 
3 +; D42-Gal4 Leo J. Pallanck (University 
of Washington) 
4 UAS-SOD1;+ Bloomington stock center 
5 UAS-SOD2;+ Bloomington stock center 
6 UAS-SOD1; D42-Gal4, UAS-mitoGFP Generated from #1 and #4 
7 UAS-SOD2; D42-Gal4, UAS-mitoGFP Generated from #1 and #5 
8 UAS-GCaMP6m;+ Bloomington stock center 
9 UAS-GCaMP6m/+; D42-Gal4/+ Generated from #3 and #8 
10 UAS-HepB2;+ Bloomington stock center 
11 UAS-Bsk RNAi;+ Vienna Drosophila RNAi 
Center (VDRC) 
12 UAS-HepB2; D42-Gal4, UAS-mitoGFP Generated from #1 and #10 
13 UAS-Bsk RNAi; D42-Gal4, UAS-mitoGFP Generated from #1 and #11 
14 UAS-HepB2/UAS-GCaMP6m; D42-Gal4/+ Generated from #9 and #10 
15 UAS-Bsk RNAi /UAS-GCaMP6m; D42-
Gal4/+ 
Generated from #9 and #11 
16 UAS-Nox RNAi/+ Vienna Drosophila RNAi 
Center (VDRC) 
17 UAS-Duox RNAi/+ Vienna Drosophila RNAi 
Center (VDRC) 
18 UAS-Nox RNAi; D42-Gal4, UAS-mitoGFP Generated from #1 and #18 







2.3 Preparation of primary neuronal cell culture and dissected larvae for live 
imaging 
 
2.3.1 Preparation of Drosophila larval primary neuronal culture 
    Prior to dissection, 4 third-instar larvae were washed with 70% ethanol once and 
endotoxin-free water for three times. Larvae were dissected in Schneider’s medium by 
pulling the mouth hook, which opened the animal’s body and exposed the brains and 
ventral ganglia. After cleaning away debris, the brains and ventral ganglia were incubated 
in Ca2+/Mg2+ free saline with 0.7 mg/ml collagenase for 1 hr at room temperature. 
Samples were centrifuged at 300 g for 3 min and washed once with Schneider’s medium. 
Tissue was then triturated with siliconized pipette tips to disperse it into  individual cells, 
which were then plated on coverslips coated with 15 µg/ml concanavalin A and incubated 
in Schneider’s medium containing 1% FBS in a humidified chamber at 25°C for 72 hrs. 
Before imaging, 50 µl of Schneider’s medium was placed on a glass slide with a single 
layer of double-sided tape as a spacer. The coverslip with cells was flipped onto the glass 
slide. The sample was then sealed with VALAP and ready for imaging. 
 
2.3.2 Drosophila larval dissection for live imaging 
    Third instar larvae were prepared using methods described previously (Pilling et al., 
2006; Devireddy et al., 2014; Devireddy et al., 2015). First, third instar larvae were 
washed with distilled water and pinned at posterior and anterior ends with the dorsal side 
up on a slygard plate (Fig. 2.1A), and moistened with HL6 buffer. A small hole was cut 
at the posterior end of the body (Fig. 2.1B) and the larva was opened by snipping through 
the cuticle with dissecting scissors (Fig. 2.1C). Muscles and fat bodies were removed 
exposing the brain, ventral ganglion, and the intact segmental nerves (Fig. 2.1D), which 
retained their connections to the muscles of the body wall. To make the larva lie flat, 4 
small lateral cuts (2 close to the anterior end and 2 close to the posterior end) were made 
in the body wall (Fig. 2.1E). The dissected larva was then moved and opened gently onto 
a glass slide containing two layers of double-sided tape as spacers (Fig. 2.1F), and the 






hook (Fig. 2.1G, H). This sample was then covered by a coverslip, incubated in HL6 
buffer, and the resulting chamber was sealed with VALAP. The whole procedure was 
done in 10 minutes. 
 
2.3.3 ROS induction in vitro and in vivo 
    To induce oxidative stress in vitro, cells were treated with 100 µM H2O2 for 1 hr, 
followed by imaging (Fang et al., 2012). To induce oxidative stress in vivo, second to 
third instar larvae were starved for 3 hr and then maintained on the standard fly food 






Figure 2.1.  Steps of in vivo larval dissection. A, Larva is pinned on a slygard plate at 
anterior and posterior positions. B, An incision is made at the posterior end. C, Larva is 
opened by cutting through the cuticle on the dorsal side. D, Fat bodies and muscles are 
cleaned to expose intact nervous system. E, Small lateral incisions are made to flatten the 
larva (4 positions at anterior and posterior ends, only shown one position here). F, Larva 
is transferred to a glass slide and body walls are opened (red arrow). G and H, Bright 
field and fluorescence images of dissected larva are shown. (Figure is adapted and 







2.4 Analysis of mitochondrial and dense core vesicle (DCV) transport 
 
2.4.1 Acquisition of time lapse confocal images 
    In vitro, mitochondria or DCVs were imaged using 60x oil-immersion objective lens 
and 3x zoom of the upright, time-lapse laser confocal microscope (LSCM, Nikon Eclipse 
90i) with a 488 nm laser (5%; 150mW laser power). The time resolution was 1 frame/s 
for a duration of 120 s. Transport of DCVs was also visualized using spinning disk 
confocal microscopy (Olympus IX-71 microscope equipped with a 60X 1.45 NA TIRFM 
PlanApo objective and Disk Scanning Unit). The time resolution in this case was 5 
frames/s for a duration of 120 s (Fig. 2.2A, B).  
    In vivo, time lapse confocal images of mitochondrial or DCV transport were acquired 
in the middle segment (A4 region) of the longest larval segmental nerves using LSCM 
with a 488 nm laser. The time resolution was 1 frame/s for a duration of 200 s (Fig. 2.2C 
– E). 
 
2.4.2 In vitro analysis of mitochondrial and DCV transport 
    For mitochondrial transport, the percentage of moving mitochondria was analyzed. The 
number of the moving or stationary mitochondria was counted using the Cell Counter 
plug-in in Image J software.  
    For DCV transport, due to the fast transport behavior, flux and velocity were analyzed 
from kymographs created by MetaMorph software. Flux is the number of vesicles 
passing an assigned point in a 60 sec period. Velocity is the average of the instantaneous 
velocity. I analyzed the flux by counting the number of the moving organelle tracks 
passing through the vertical midline of the kymograph. Velocity was calculated from the 
slope of the lines in kymographs. Anterograde transport is defined as the transport toward 
synaptic terminals; retrograde transport is defined as the transport toward to cell bodies.  
 
2.4.3 In vivo analysis of mitochondrial and DCV transport 
    Kymographs of mitochondrial or DCV transport in vivo were prepared using Nikon 






individual mitochondria or DCVs by marking the x-y positions of every vesicle in every 
frame. A stationary vesicle was also “tracked” as a reference point to eliminate the effects 
of larval moving or stage drift. These positional data were used to analyze different 
parameters of transport behavior described as follows (Devireddy et al., 2014; Devireddy 
et al., 2015):  
1. Run is the motion sustained in at least three frames with the velocity larger than 
0.1 μm/s or smaller than -0.1μm/s. 
2. Flux is defined as the number of vesicles that cross an assigned point in one-
minute interval. In a 200 s period, I recorded how many mitochondria moved 
anterogradely and retrogradely across a line drawn in the center of the movie 
frame.   
3. Velocity is the average of velocity of each run. Velocity was considered as run 
velocity only rather than average velocity including pauses. This run velocity was 
determined by the total length/total time of all runs.  
4. The percentage of moving vesicles is the fraction of vesicles that move either 
anterogradely or retrogradely. Cell Counter pulg-in was used to count the number 
of moving or stationary mitochondria. 
5. Duty cycle is the percentage of time spent moving in a particular direction, 
anterograde, retrograde, or paused.  
6. Run length is the average moving distance per run. Typically I used total distance 
















Figure 2.2. GFP expression of mitochondria or DCVs in vivo and in vitro. A and B, 
Mitochondria (A) and DCVs (B) are shown in primary neuronal cell culture. C, all 8 
segments, segmental nerves (SNs), and ventral ganglion (VG) are shown. The white box 
shows the A4 (Abdominal segment 4) region of the longest segmental nerves, used for 
visualizing transport. D and E, Mitochondria (D) and DCVs (E) are shown in the A4 
region of the longest segmental nerves. Scale bars in (A,B,D,E) indicates 10 µm. (Figure 













2.5 Measurement of mitochondrial membrane potential 
 
2.5.1 TMRM treatment in cell culture 
    A 20 mM tetramethylrhodamine methyl ester (TMRM) stock was prepared in DMSO. 
A 25 µM TMRM working stock was prepared freshly for each experiment by diluting the 
first stock with DMSO. Cells were incubated in Schneider’s medium containing 25 nM 
TMRM for 10 minutes, and washed once with 6.25 nM TMRM washing solution. The 
treated samples were imaged in washing solution to maintain dye equilibrium. All 
procedures were performed avoiding light exposrue (Shidara and Hollenbeck, 2010; 
Devireddy et al., 2014; Devireddy et al., 2015). 
 
2.5.2 Imaging and quantification of TMRM intensity 
    Cells were imaged using 60x oil-immersed objective lens with 3x zoom of confocal 
microscope (Nikon Eclipse 90i) with 5% 488 nm and 561 nm laser. To image motor 
neurons specifically, cells containing green signals due to the expression of mitoGFP 
driven by D42-Gal4 were selected .The laser power of the 561 nm channel was 
sometimes adjusted to prevent saturated exposure in the images.   
    To quantify the TMRM intensity, images were thresholded in the intensity range 
between 350 and 4095 units (highest intensity: 4095) and the intensity of mitochondrial 
fluorescence (Fm) was measured using Nikon NIS-Elements software. The fluorescence 
intensity in cytosol (Fc) was determined as the average intensity of two 5 pixel x 5 pixel 
regions next to the mitochondria. The mitochondrial membrane potential was then 
expressed as the intensity ratio of mitochondrial fluorescence to cytosolic fluorescence 
(Fm/Fc) which is logarithmically related to mitochondrial membrane potential. 
 
2.6 Quantification of mitochondrial density and lengths 
 
2.6.1 Quantification of mitochondrial density 
    Mitochondrial density was determined by finding the total mitochondrial pixels in 






second frame of the time lapse images was used to reduce background noise and sharpen 
the image by low-pass Laplace filters in the software. Then the image was thresholded at 
350 intensity units and binarized. From this binary image, integrated mitochondrial pixels 
(number of mitochondrial pixels divided by total pixels in the nerve field) were measured 
as mitochondrial density. 
 
2.6.2 Quantification of mitochondrial length 
    In cell culture, only mitochondria in the processes were selected for length 
measurement. Mitochondrial length was measured using Annotations and Measurements/ 
Length/2 Points or Polyline function in Nikon NIS-Elements software. 
 
2.7 Measurement of Ca2+ levels and analysis of transport affected by Ca2+ 
 
2.7.1 Ca2+ chelation and release in cell culture 
    Neuronal cells expressing GCaMP6 in motor neurons (UAS-GCaMP6m/+; D42-
Gal4/+) were used to visualize Ca2+ levels. Before treatment, cells were washed three 
times with sterile S2 saline. To chelate extracellular Ca2+, cells were incubated in Ca2+-
free saline (S2 saline without CaCl2) containing 0.1 mM EGTA for 30 minutes. To 
remove both extracellular and intracellular Ca2+, cells were incubated in Ca2+-free saline 
containing 0.1 mM EGTA and 10 µM BAPTA-AM for 30 minutes (Kim and Sharma, 
2004; Yeromin et al., 2004; Huang et al., 2014). To induce ROS in Ca2+ chelation 
conditions, cells were incubated in above-described solutions containing 100 µM H2O2 
for 1 hr. After incubation, cells were prepared for imaging. 
    To artificially increase intracellular Ca2+ levels dramatically, cells were treated with S2 
saline containing 10 µM ionomycin, an ionophore. To induce intracellular Ca2+ levels 
from the intracellular Ca2+ pool, cells were treated with S2 saline containing 2 µM 
thapsigargin, an ER Ca2+-ATPase inhibitor (Yeromin et al., 2004). After treatment, cells 







2.7.2 Imaging and quantification of Ca2+ levels 
    Cells were imaged using a 60x oil-immersion objective lens with 3x zoom on the 
confocal microscope (Nikon Eclipse 90i) using 10% power from the 488 nm laser. To 
image motor neurons specifically, cells containing green signals due to the expression of 
GCaMP6 driven by D42-Gal4.were selected. 
    To quantify the Ca2+ levels, images were thresholded in the intensity range between 30 
and 4095 units (highest intensity: 4095) and the intensity of Ca2+ was measured in whole 
cells using Nikon NIS-Elements software. Total intensity/total area was used to get the 
average intensity of Ca2+ in a cell. 
 
2.7.3 Imaging the effects of Ca2+ on transport 
    To determine the effects of elevated Ca2+ on mitochondrial or DCV transport, 10 µM 
ionomycin or 2 µM thapsigargin was used as in section 2.7.1, above. Before treatment, 
cells were washed with S2 saline for three times and imaged using the in vitro settings as 
in section 2.4.1, above. The same sample was then treated with S2 saline containing 10 
µM ionomycin or 2 µM thapsigargin. After treatment, the same cell was imaged again 
immediately. To analyze transport, the percentage of mitochondria transport or velocity 
of DCV of the same cell before and after treatment was analyzed using the methods 
described in section 2.4.2, above.  
    To determine the effects of Ca2+ chelation on mitochondrial transport, conditions of 
treatment were the same as in section 2.7.1, above. The settings for the acquisition and 
analysis were the same as in sections 2.4.1 and 2.4.2, respectively. 
 
2.8 Statistics 
    All statistical analysis was performed using GraphPad Prism 5 software. All error bars 
in graphs indicate mean ± SEM. In the in vivo studies, the experimental unit is an 
individual larva. In the in vitro studies, the experimental unit is a cell. Data were analyzed 
using a one-way ANOVA with Bonferroni’s post-test for multiple group comparisons, 






independent experiments were performed. The specific type of statistical analysis was 








CHAPTER 3. RESULTS 
3.1 Mitochondrial transport in axons is reduced in response to oxidative stress 
 
3.1.1 Mitochondrial transport is reduced in vitro in response to oxidative stress     
    Impairment of the axonal transport of mitochondria has been shown to correlate 
with neurodegenerative diseases (Saxton and Hollenbeck, 2012; Sheng and Cai, 
2012). However, how ROS production might circle back to regulate mitochondrial 
transport, an issue that may be important in the pathophysiology of neurodegeneration, 
is still unknown.  Diminished overall mitochondrial transport under oxidative stress 
conditions has been shown in cultured neurons (Fang et al., 2012). Thus, I first 
examined whether oxidative stress affected mitochondrial transport in Drosophila 
primary neuron cell cultures obtained from brains and ventral ganglia of third instar 
larvae expressing mtiochondrially-targeted GFP in motor neurons.  
    To induce oxidative stress, I treated cells with 100 µM H2O2 for 1 hr and found that 
the percentage of moving mitochondria in axons decreased significantly (Fig. 3.1A, 
B). Longer periods of treatment (up to 3 hrs) did not produce any further reduction in 
mitochondrial motility (Fig. 3.1C). These results indicate that in Drosophila primary 
neuronal cell cultures, mitochondrial transport is diminished under conditions of 
oxidative stress, consistent with previous in vitro studies (Fang et al., 2012). 
 
3.1.2 Mitochondrial transport is reduced in vivo in response to oxidative stress 
    Although the results showed that oxidative stress reduced mitochondrial transport 
in cultured neurons, it remained unknown whether or not ROS affect mitochondrial 
transport in axons of the nervous system in vivo.  In the more complex in vivo 







 pO2 is lower than in vitro. Thus, I quantified different parameters of mitochondrial 
transport under oxidative stress conditions in vivo in 3rd instar larvae expressing 
mito-GFP in their motor neurons and prepared as previously described (Shidara et al, 
2010; Devireddy et al, 2014).  I expected that, as in vitro, an in vivo ROS increase 
would affect mitochondrial transport. To induce oxidative stress in the larval nervous 
system, I treated larvae with  20 mM paraquat for 24 hrs (Lee et al., 2009), and 
quantified mitochondrial movements in axons in the central region of the longest 
segmental nerves (Devireddy et al., 2014).  
    In axons, moving mitochondria are categorized into anterograde and retrograde 
populations by their dominant and net direction of movement, which is easily 
distinguishable despite pauses and brief reversals of direction. I first quantified flux, 
which is a gross indicator of movement representing how many mitochondria pass a 
fixed point per unit time. I found reduced mitochondrial flux in both the anterograde 
and retrograde populations after paraquat treatment in vivo (Fig. 3.2A, B). To perform 
a more detailed analysis and determine the possible mechanisms decreasing flux, I 
examined more specific parameters of mitochondrial transport: velocity, duty cycle, 
run length, percentage of moving mitochondria, and density (Devireddy et al., 2014). 
Under oxidative stress conditions, I found reduced run velocities in both directions 
(Fig. 3.2C), of a magnitude nearly large enough to explain the reduction in flux. In 
addition, duty cycle was modestly-reduced in the retrograde direction (Fig. 3.3A). 
Due to the reduction of velocity and duty cycle, retrograde run length was also 
modestly reduced (Fig. 3.3B). Moreover, reduced flux was caused by an increased 
percentage of stationary mitochondria (Fig. 3.3C). Mitochondrial density is not 
directly linked to motility, but reduced density can definitely contribute to reduced 
flux. However, there was no significant difference in mitochondrial density of 
segmental nerve axons under oxidative stress conditions (Fig. 3.3D), indicating that 








3.2 Overexpression of SOD attenuates defects of mitochondrial transport 
under oxidative stress conditions 
 
3.2.1 Overexpression of SOD rescues ROS-induced defects of mitochondrial 
transport in vitro 
    Superoxide dismutase (SOD), a well-characterized anti-oxidant enzyme, converts 
superoxide to H2O2 (Matés et al., 1999; Fischer et al., 2012). Overexpression of SOD 
has been shown to relieve oxidative stress in Drosophila (Parkes et al., 1998; Elia et 
al., 1999). To ensure that the reduced mitochondrial transport observed above was 
specifically caused by oxidative stress, I overexpressed cytosolic SOD (SOD1) or 
mitochondrial SOD (SOD2) under oxidative stress conditions, with the expectation 
that ROS-induced defects in mitochondrial transport would be rescued. As expected, 
the defects in the percentage of moving mitochondria in vitro were fully rescued by 
overexpression of either SOD1 or SOD2 (Fig. 3.1A, B), indicating that the defects of 
mitochondrial transport were specifically caused by oxidative stress in vitro. 
 
3.2.2 Overexpression of SOD rescues ROS-induced defects of mitochondrial 
transport in vivo 
    In vivo, both the reduced flux and velocity produced by paraquat were rescued by 
SOD1 or 2 overexpression (Fig. 3.2). In the retrograde direction, both the modestly-
reduced duty cycle and run length were also rescued (Fig. 3.3A, B). For the 
percentage of moving mitochondria in vivo, the increase in stationary mitochondria 
was rescued (Fig. 3.3C). Interestingly, SOD2 overexpression alone produced an 
increase in the percentage of anterograde moving mitochondria. In addition, under 
oxidative stress conditions, SOD2 overexpression produced an increased percentage 
of retrograde moving mitochondria (Fig. 3.3C), suggesting that mitochondrial SOD 
overexpression could play a role in recycling mitochondria back to cell bodies. These 
results indicate that inducing a reduction of excess ROS levels can diminish the 
defects in mitochondrial transport in vivo. On the other hand, there is no significant 
difference in axonal mitochondrial density compared to controls with SOD1 or 2 







and/or the traffic steady state were not affected by the overexpression. In sum, these 
results indicate that excess ROS do produce defects of mitochondrial transport both in 




































Figure 3.1. The percentage of moving mitochondria is reduced in response to 
ROS and rescued by SOD overexpression in vitro. A, Representative kymographs 
of mitochondrial transport under H2O2 treatment. Anterograde transport is toward the 
right; retrograde transport is toward the left. B, The percentage of moving 
mitochondria is reduced with H2O2 treatment. SOD1 or SOD2 overexpression can 
rescue the defect. C, The percentage of moving mitochondria decreases with the same 
levels after H2O2 treatment for 1 to 3 hrs. Number of cells is shown on bars. Error 
bars indicate mean ± SEM. Significance is determined by one-way ANOVA with 











Figure 3.2. ROS change mitochondrial motility mainly by reducing flux and 
velocity in vivo. A, Representative kymographs of mitochondrial transport under 
paraquat treatment. Anterograde transport is toward the right; retrograde transport is 
toward the left. B, Paraquat treatment produces a decrease in mitochondrial flux, 
which is rescued by overexpression of SOD1 or SOD2 in both directions. C, Velocity 
is reduced with paraquat treatment, which is rescued by SOD1 or SOD2 
overexpression in both directions. Number of larvae is shown on bars. Error bars 
indicate mean ± SEM. Significance is determined by one-way ANOVA with 






















Figure 3.3. ROS modestly affect mitochondrial duty cycle, run length, and 
percentage of moving mitochondria in vivo. A, Paraquat treatment gives a small 
reduction in retrograde duty cycle with an increase of pause time and a decrease of 
moving time; overexpression of SOD1 shows a small increase of pause time. B, 
Retrograde run length is modestly reduced with paraquat treatment. C, Paraquat 
treatment shows an increase of the percentage of stationary mitochondria, which is 
rescued by SOD overexpression. The percentage of anterograde moving mitochondria 
increases with SOD2 overexpression. D, Mitochondrial density is comparable to 
control with paraquat treatmen or SOD overexpression. Number of larvae is shown 
on bars. Error bars indicate mean ± SEM. Significance is determined by one-way 
























3.3 Transport of neuropeptide-bearing large DCVs is barely affected in the 
presence of ROS 
 
3.3.1 DCV transport is barely affected in response to oxidative stress in vitro 
    To test whether the defects of transport in response to oxidative stress are specific 
to mitochondria, I further investigated fast axonal transport of other cargoes. To 
examine this, ANF (atrial natriuretic peptide)-GFP, a GFP fusion targeted to the 
lumen of neuropeptide-bearing DCVs, was expressed in motor neurons using the 
D42-Gal4 driver (Barkus et al., 2008).   
    In vitro, time lapse images were taken using a spinning disk confocal microscope 
with 5 frames/s time resolution. Then images were converted to kymographs for 
analysis of flux and velocity (Fig. 3.4A). Under oxidative stress conditions, the flux 
of DCV transport was not affected in either direction (Fig. 3.4B).  Velocity analysis 
showed that only retrograde, but not anterograde, velocity was modestly affected (Fig. 
3.4C). These results indicate that DCV transport is barely affected under oxidative 
stress conditions in vitro. 
 
3.3.2 DCV transport is not affected in response to oxidative stress in vivo 
    In vivo, detailed parameters of DCV transport in response to ROS -- including 
velocity, duty cycle, run length, and density -- were analyzed (Fig 3.5). As with the in 
vitro results, all of parameters under paraquat treatment were comparable to controls, 
indicating that DCV transport is not affected by oxidative stress conditions (Fig 3.5B-
D). In addition, since the DCV density is unchanged (Fig. 3.5E), DCV biogenesis and 
degradation appear to be maintained in their normal steady state. Thus, based upon 
both in vitro and in vivo results, I conclude that oxidative stress impedes 












Figure 3.4. DCV transport is nearly unaffected by ROS treatment in vitro. A, 
Representative kymographs of DCV transport in vitro. Anterograde transport is 
toward the right; retrograde transport is toward the left. B, There is no significant 
difference in both anterograde and retrograde flux of DCV transport with H2O2 
treatment. C, Retrograde velocity of DCV transport is reduced with H2O2 treatment. 
Number of plates is shown on bars. Each plate contains at least 5 cells. Error bars 




















Figure 3.5. DCV transport is unaffected by ROS treatment in vivo. A, 
Representative kymographs of DCV transport in vivo. Anterograde transport is 
toward the right; retrograde transport is toward the left. B-E, Parameters in DCV 
transport with paraquat treatment including velocity (B), duty cycle (C), run length 
(D), and density (E) are comparable to controls. Number larvae is shown on bars. 
















3.4 Endogenous Nox and Duox play roles in the regulation of mitochondrial 
transport 
    It has been shown that excessive ROS induce oxidative stress and cellular damage. 
However, recent evidence makes it clear that endogenous ROS are important 
signaling molecules required for different functions such as wound response, muscle 
contraction, and neurite outgrowth, among other roles. (Ritsick et al., 2007; Razzell et 
al., 2013; Munnamalai et al., 2014; Nayernia et al., 2014). So aside from excessive 
ROS, it is unclear whether endogenous ROS levels also affect mitochondrial transport 
in axons. To examine this, NADPH oxidase (Nox) and Dual oxidase (Duox) were 
down-regulated by RNAi in motor neurons and mitochondrial transport was 
examined in vivo.  
    I examined different parameters including flux, velocity, duty cycle, run length, 
percentage of moving mitochondria and density in both directions under Nox or Duox 
down-regulation (Fig. 3.6 and 3.7). Interestingly, all transport parameters were 
reduced in both directions with Nox down-regulation (Fig. 3.6 and 3.7), indicating 
that endogenous ROS are required for mitochondrial transport. On the other hand, 
only retrograde mitochondrial transport showed a general reduction with Duox down-
regulation (Fig. 3.6 and 3.7), suggesting a directional difference of influence between 
Duox and Nox. Furthermore, only run length decreased in the anterograde direction 
(Fig. 3.7B), suggesting that the specific motility pattern is affected by Duox 
knockdown. Mitochondrial density under down-regulation of Nox or Duox was 
comparable to controls, indicating the observed defects were due to transport 
behavior.  These data suggest that either abnormally high or low levels of ROS affect 
mitochondrial movement in axons, implying that physiological ROS levels are crucial 
for mitochondrial transport. This also raises the possibility that the defects of 
mitochondrial transport observed under conditions of excessive ROS are caused not 












Figure 3.6. Endogenous ROS affect mitochondrial flux and velocity in vivo. A, 
Representative kymographs of mitochondrial transport with knockdown of Duox or 
Nox. Anterograde transport is toward the right; retrograde transport is toward the left. 
B, Knockdown of Duox produces a decrease in mitochondrial flux retrogradely, but 
knockdown of Nox reduces flux in both directions. C, Velocity is reduced in both 
direcitions by down-regulation of Nox, but is reduced only in the retrograde direction 
by down-regulation of Duox Number of larvae is shown on bars. Error bars indicate 
mean ± SEM. Significance is determined by one-way ANOVA with Bonferroni’s 



























Figure 3.7. Endogenous ROS affect mitochondrial duty cycle, run length, and 
the percentage of moving mitochondria in vivo. A, Knockdown of Nox gives a 
reduction in duty cycle with an increase of pause time and a decrease of moving time 
in both directions. Knockdown of Duox decreases retrograde duty cycle and increases 
pause time in anterograde direction. B, Run length is reduced by knockdown of Duox 
or Nox in both directions. C, Knockdown of Duox shows a decrease of the percentage 
of retrograde moving mitochondria. Knockdown of Nox shows an increase of the 
percentage of paused mitochondria and a decrease of the percentage of anterograde 
moving mitochondria. D, Mitochondrial density is comparable to control with 
knockdown of Duox or Nox. Number of larvae is shown on bars. Error bars indicate 
mean ± SEM. Significance is determined by one-way ANOVA with Bonferroni’s 



















3.5 Mitochondrial fission-fusion balance and inner membrane potential are 
both diminished by ROS treatment 
 
3.5.1 Mitochondrial length is reduced under oxidative stress conditions 
    Different elements of the mitochondrial life cycle including mitochondrial length, 
membrane potential, transport, and mitophagy are highly interrelated. For example, 
mutation of mitochondrial fusion protein, mitofusin 2, both induces mitochondrial 
fragmentation and reduces mitochondrial transport (Verstreken et al., 2005; Baloh et 
al., 2007; Misko et al., 2010; Misko et al., 2012).  
    To determine whether disrupted mitochondrial transport caused by ROS is 
accompanied by changes in fission-fusion steady state, mitochondrial length was 
examined after H2O2 treatment for 1 hr. After treatment, mitochondrial shapes became 
more rounded and length was reduced (Fig. 3.8A, B), indicating that excess ROS 
affect the mitochondrial fission-fusion steady state by reducing mitochondrial length. 
In addition, overexpression of SOD1 or SOD2 fully rescued the reduced 
mitochondrial length (Fig. 3.8A, B), further confirming that these morphological 
defects are produced by oxidative stress. 
 
3.5.2 Mitochondrial membrane potential is reduced under oxidative stress 
conditions 
    Mitochondrial membrane potential and mitochondrial transport may be correlated 
(Miller and Sheetz, 2004; Saxton and Hollenbeck, 2012). Thus, I also examined 
whether ROS-induced inhibition of mitochondrial transport was accompanied by 
diminished membrane potential. To test this, mitochondria were stained with TMRM 
and mitochondrial membrane potential was expressed as the intensity ratio of 
mitochondrial and cytosolic TMRM fluorescence.  
    Under oxidative stress conditions, mitochondrial membrane potential was reduced, 
indicating that the mitochondrial metabolic state is disrupted (Fig. 3.8A, C). However, 
SOD1 or SOD2 overexpression did not rescue the diminished mitochondrial 
membrane potential caused by ROS (Fig. 3.8A, C), suggesting that SOD 







scavengers, including glutathione peroxidase or catalase, might be required to restore 
the normal metabolic state. Altogether, these data indicate that oxidative stress 
produces imbalances in mitochondrial fission-fusion and metabolic state, and suggest 
that mitochondrial transport, fission-fusion, and membrane potential are closely 


































Figure 3.8. Mitochondrial length and membrane potential are reduced in 
response to ROS. A, Representative images of mitochondrial length and membrane 
potential. Mitochondrial lengths are measured using mitoGFP signals and 
mitochondrial membrane potential is measured using TMRM staining by the intensity 
ratio of mitochondrial fluorescence and cytosolic fluorescence. Scale bars indicate 10 
µm. B, Quantitative results of mitochondrial length. ROS treatment shows a decrease 
of mitochondrial length, which is rescued by SOD1 or SOD2 overexpression. C, 
Quantitative results of mitochondrial membrane potential. Mitochondrial membrane 
potential is reduced under oxidative stress conditions. SOD1 or SOD2 overexpression 
does not rescue these defects. Number of cells is shown on bars. Error bars indicate 
mean ± SEM. Significance is determined by one-way ANOVA with Bonferroni’s 













3.6 ROS-induced defects of mitochondrial transport are caused by Ca2+ levels 
 
3.6.1 ROS elevate intracellular Ca2+ levels 
    Mitochondrial transport is inhibited by Ca2+ levels. Mitochondria have Miro 
proteins that contain Ca2+ binding EF-domain. When Ca2+ levels increase, Ca2+ binds 
the EF-domain on Miro and mitochondrial transport is inhibited (Macaskill et al., 
2009; Wang and Schwarz, 2009; Chen and Sheng, 2013). In addition, it has been 
shown that Ca2+ and redox signaling have significant interactions. ROS could 
stimulate Ca2+ influx via different Ca2+ channels including voltage-dependent Ca2+ 
channels or channels involved in receptor-induced Ca2+ signals (Hidalgo and Donoso, 
2008; Gleichmann and Mattson, 2011; Görlach et al., 2015). Thus, the defects of 
mitochondrial transport caused by oxidative stress might be regulated by elevated 
Ca2+ levels.  
    To determine whether the defects in mitochondrial transport in response to ROS 
are related to intracellular Ca2+ levels, Ca2+ levels were measured using the 
genetically-encoded calcium indicator GCaMP6 which I expressed in motor neurons 
using the D42-Gal4 driver (Chen et al., 2013). After 1 hr H2O2 treatment, cells 
showed about 50% higher GCaMP6 intensity compared to controls (Fig. 3.9), 
indicating that ROS do indeed induce increased intracellular Ca2+ levels. I also treated 
cells for a longer period with ROS and found no further increase in GCaMP intensity, 
consistent with the result that longer ROS treatment did not produce further reduced 
mitochondrial transport (Fig. 3.1C, above). 
 
3.6.2 Elevated Ca2+ levels inhibit mitochondrial transport specifically 
    While Ca2+ has been shown to inhibit mitochondrial transport in different systems 
(Macaskill et al., 2009; Wang and Schwarz, 2009; Chen and Sheng, 2013), whether 
Ca2+ inhibits mitochondrial transport in our system is still unknown. I first artificially 
induced Ca2+ levels dramatically by  treating cells with the Ca2+ ionophore, 
ionomycin (Fig. 3.9A, B), and examined both mitochondrial transport and DCV 







(Fig. 3.10B). Compared to controls, the velocity of DCV transport in ionomycin-
treated cells did not show a significant difference (Fig. 3.10C).  
    Although mitochondrial transport was reduced in ionomycin-treated cells, Ca2+ 
levels were much higher than physiological or ROS-treated levels. To confirm that 
the reduction did not require a dramatic increase of Ca2+ levels, I treated cells with 
thapsigargin, an ER Ca2+ ATPase inhibitor that increases only intracellular Ca2+ 
levels, to mimic Ca2+ levels under oxidative stress (Fig. 3.9A, B). Under these 
conditions, the percentage of moving mitochondria was reduced to a similar level to 
that seen in H2O2-treated cells (Fig. 3.1, 3.10D, E). In addition, the velocity of DCV 
transport was similar to controls (Fig. 3.10D, F), further confirming that elevated Ca2+ 
levels reduced mitochondrial transport specifically. 
 
3.6.3 ROS-induced defects of mitochondrial transport is mediated by Ca2+ levels 
    The results reported in sections 3.6.1 and 3.6.2 indicate that ROS increase 
intracellular Ca2+, and that artificially increased Ca2+ levels reduce mitochondrial 
transport, supporting the hypothesis that ROS produce defects of mitochondrial 
transport through the elevation of Ca2+ levels.  To test further the hypothesis, the 
ROS-induced increase in Ca2+ levels was stymied by incubating cells in Ca2+-free 
medium containing EGTA. Under these conditions, I examined whether ROS-
induced defects of mitochondrial transport were rescued. 
    Before examining transport, I first confirmed that EGTA treatment did reduce Ca2+ 
levels, using the GCaMP6 indicator (Fig. 3.11A, B). EGTA treatment alone did not 
decrease intracellular Ca2+ levels, but it rescued the ROS-induced Ca2+ levels to 
physiological levels (Fig. 3.11A, B). Next, I examined mitochondrial transport under 
these conditions. Under ROS treatment with Ca2+ levels held to control levels, the 
percentage of moving mitochondria was similar to controls (Fig. 3.11C, D). In 
addition, the ROS-reduced percentage of moving mitochondria was partially rescued, 
indicating that ROS-induced defects of mitochondrial transport are mediated in large 








3.6.4 Ca2+ homeostasis is required for mitochondrial transport 
    Since EGTA treatment, rescuing Ca2+ to physiological levels, rescued ROS-
induced defects of mitochondrial transport, I wondered whether further reduction of 
Ca2+ levels could increase mitochondrial transport. To examine this, cells were 
treated with both EGTA and BAPTA-AM, a Ca2+ chelator that can cross the cell 
membrane, to further reduce intracellular Ca2+ levels (Fig. 3.11E, F). First, I showed 
that  cells incubated with H2O2, EGTA, and BAPTA-AM also showed reduced Ca2+ 
levels compared to controls (Fig. 3.11E, F), indicating that combined intracellular and 
extracellular Ca2+ chelation indeed reduces Ca2+ levels lower than physiological 
levels.  
    Surprisingly, cells with Ca2+ levels lower than physiological levels also showed 
unexpected defects in mitochondrial transport. The percentage of moving 
mitochondria was reduced under these conditions (Fig. 3.11G, H), indicating that 
lower Ca2+ levels also inhibit mitochondrial transport.  
    Altogether, these data suggest that Ca2+ homeostasis is required for mitochondrial 
transport, and that modulation of Ca2+ levels mediates the effect of ROS on 
mitochondria. 
 
3.6.5 Ca2+ homeostasis is required for mitochondrial transport 
    Mitochondrial fission-fusion steady state has been shown to correlate to 
mitochondrial transport. Disruption of the fission-fusion steady state by mutation of 
mitochondrial fusion protein, Mitofusin, produces mitochondrial fragment and 
reduced mitochondrial movement (Verstreken et al., 2005; Baloh et al., 2007; Misko 
et al., 2010; Misko et al., 2012). I have shown that oxidative stress reduced both 
mitochondrial transport and length (Fig. 3.8A, B). To examine whether the Ca2+-
induced defects of mitochondrial transport are also related to mitochondrial length 
control, I measured the mitochondrial length under the conditions described in section 
3.6.4.  
    I found that the mitochondrial length reduction caused by oxidative stress was 
rescued by EGTA treatment but was not rescued by combined BAPTA-AM and 







H). These results indicate that either higher or lower Ca2+ levels affect mitochondrial 
length. All together, these data indicate that Ca2+ homeostasis is important for both 




































Figure 3.9. Elevated Ca2+ levels are induced by H2O2. A, Representative Ca
2+ 
imaging with H2O2, thapsgargin, or ionomycin treatment are measured by the 
intensity of GCaMP6 indicator. Scale bars indicate 10 µm. B, Quantitative results 
from (A). H2O2 or thapsgargin treatment produces an increase of Ca2+ levels of 
similar extent. Ionomycin treatment produces a large increase compared to controls. 
Number of cells is shown on bars. Each plate contains at least 5 cells. Error bars 
indicate mean ± SEM. Significance is determined by one-way ANOVA with 




















Figure 3.10. Elevated Ca2+ levels inhibit mitochondrial transport. A, 
Representative kymographs of axonal transport of mitochondria or DCVs under 
ionomycin treatment. Anterograde transport is toward the right; retrograde transport 
is toward the left. B, The percentage of moving mitochondria is dramatically reduced 
by ionomycin treatment. C, Velocity of DCV transport is not affected by ionomycin. 
D, Representative kymographs of axonal transport of mitochondria or DCVs with 
thapsigargin treatment. E, The percentage of moving mitochondria is reduced by 
thapsigargin treatment, but the effect is not as large as ionomycin treatment. F, 
Velocity of DCV transport is not affected by thapsigargin. Number of cells is shown 
on bars. Error bars indicate mean ± SEM. Significance is determined by paired 















Figure 3.11. Ca2+ homeostasis is required for normal mitochondrial transport. A, 
Representative Ca2+ imaging with H2O2 or EGTA treatment are measured by the 
intensity of GCaMP6 indicator. Scale bars indicate 10 µm. B, Quantitative results 
from (A). Elevated Ca2+ levels induced by H2O2 are rescued by EGTA treatment. 
EGTA alone does not affect intracellular Ca2+ levels. C, Representative kymographs 
of mitochondrial transport under H2O2 or EGTA treatment. Anterograde transport is 
toward the right; retrograde transport is toward the left. D, The reduced percentage of 
moving mitochondria by H2O2 is partially rescued by EGTA. EGTA alone does not 
affect mitochondrial transport. E, Representative Ca2+ imaging with H2O2 or 
EGTA/BAPTA treatment are measured by the intensity of GCaMP6 indicator. Scale 
bars indicate 10 µm. F, Quantitative results from (E). Ca2+ levels are increased by 
H2O2 but reduced with EGTA/BAPTA treatment. G, Representative kymographs of 
mitochondrial transport with H2O2 or EGTA/BAPTA treatment. Anterograde 
transport is toward the right; retrograde transport is toward the left. H, 
EGTA/BAPTA treatment produces a decrease of mitochondrial transport. The 
reduced percentage of moving mitochondria by H2O2 is further reduced by 
EGTA/BAPTA treatment. Error bars indicate mean ± SEM. Number of cells is shown 
on bars. Significance is determined by one-way ANOVA with Bonferroni’s post-test. 











Figure 3.12. Ca2+ homeostasis is required for normal mitochondrial morphology. 
A, Representative images of mitochondrial length measured using the mitoGFP signal. 
Scale bars indicate 10 µm. B, H2O2 and/or EGTA/BAPTA reduce mitochondrial 
length, which is consistent with the results of mitochondrial transport (Fig. 3.11D, H). 
Error bars indicate mean ± SEM. Number of cells is shown on bars. Significance is 
determined by one-way ANOVA with Bonferroni’s post-test. **p < 0.01, and ***p < 























3.7 The JNK pathway plays a role in the regulation of mitochondrial transport 
in axons by oxidative stress 
    It seems clear so far that the effects of ROS exposure on mitochondrial transport 
are probably not due simply to generalized oxidative damage, but probably involve an 
imbalance of normal ROS-based signaling. To investigate this further, I examined the 
JNK pathway, which is activated under oxidative stress conditions (Shen and Liu, 
2006; Son et al., 2013) and involved in regulating axonal transport (Morfini et al., 
2006; Morfini et al., 2009).  Previous studies have shown that activated JNK pathway 
reduces axonal transport in squid axoplasm via the phosphorylation of kinesin heavy 
chain (Morfini et al., 2006). Thus, I hypothesized that ROS induced defects of 
mitochondrial transport involve the activation of the JNK pathway. 
 
3.7.1 Mitochondrial transport is not affected by JNK signaling in vitro 
    To test this hypothesis, I activated the JNK pathway by overexpressing HepB2 
(JNK kinase in Drosophila), or down-regulated it by RNAi knockdown of Bsk (JNK 
in Drosophila). I expected that mitochondrial transport would increase with the 
down-regulation of the JNK pathway and decrease with the activation of the JNK 
pathway. 
    However, when I examined the percentage of moving vs. persistently stationary 
mitochondria in Drosophila neurons in vitro, I did not find significant differences 
between control and JNK activation/down-regulation under basal conditions. In 
addition, under oxidative stress, the percentage of moving mitochondria was reduced 
in both overexpression and knockdown animals (Fig. 3.13), suggesting that JNK 
signaling is not involved in the regulation of mitochondrial transport in response to 
ROS in vitro. 
 
3.7.2 The JNK signaling pathway plays a role in the regulation of mitochondrial 
transport under oxidative stress in vivo 
    Previous studies have shown that the JNK pathway affected axonal transport 
mainly in anterograde direction (Morfini et al., 2006; Morfini et al., 2009). It is 







reveal directional defects. To determine more accurately whether the JNK pathway 
affected mitochondrial transport only in one direction, I examined more detailed 
parameters in vivo. 
    First, I examined the gross transport indicator, flux. In the anterograde direction, 
flux was reduced by JNK activation. In addition, under oxidative stress conditions, 
flux was not further reduced by JNK activation (Fig. 3.14A, B), implying that the 
JNK pathway is downstream of the effects of oxidative stress on anterograde 
mitochondrial flux.  Furthermore, the ROS-induced defects in anterograde flux were 
partially rescued by JNK knockdown (Fig. 3.14A, B), also suggesting that the JNK 
pathway plays a role in mediating the inhibition of mitochondrial anterograde 
transport by oxidative stress. To analyze which parameters resulted in the reduced 
flux, velocity, duty cycle, run length, and the percentage of mitochondria were 
examined. Similar to the flux results, activation of the JNK pathway reduced 
mitochondrial velocity (Fig. 3.14A, C), and down-regulation of JNK partially rescued 
the reduced velocity caused by ROS treatment in the anterograde direction (Fig. 
3.14A, C), indicating that the velocity is one of the factors contributing to the 
difference in flux.  
    However, for retrograde movement, either activation or down-regulation of the 
JNK pathway produced a decrease of mitochondrial flux and velocity under oxidative 
stress conditions (Fig. 3.14A-C), suggesting that other mechanisms might be 
responsible for the regulation of the effects of oxidative stress on retrograde 
mitochondrial transport.  Thus, although the regulatory systems are directionally 
differentiated, optimal levels of activity in the JNK pathway are important for 
mitochondrial transport in both directions. Other parameters of mitochondrial motility 
such as duty cycles, run length, and the percentage of moving mitochondria were only 
modestly affected by either overexpression or knockdown of the JNK pathway (Fig. 
3.15), indicating that JNK signaling mediates mitochondrial flux in response to ROS 








3.7.3 Activation of the JNK pathway shows a decrease of mitochondrial density 
    In addition to transport parameters, mitochondrial density was examined under 
these conditions (Fig. 3.16). Surprisingly, activation of the JNK pathway produced a 
decrease in axonal mitochondrial density (Fig. 3.16). This reduced density did not 
further decrease under oxidative stress conditions (Fig. 3.16), suggesting that the 
activation of the JNK pathway might reduce mitochondrial biogenesis and/or increase 
mitochondrial degradation. In addition, the reduced density also implicates another 
component of the mitochondrial life cycle that could contribute to the difference in 
the flux.  
    In sum, these results demonstrated that the JNK pathway, activated by oxidative 
stress, plays a role in the regulation of mitochondrial transport in the anterograde 
direction, consistent with the role of JNK in the regulation of anterograde-specific 
axonal transport. In addition to mitochondrial transport, the JNK pathway also plays a 
role in the regulation of mitochondrial density, suggesting the important role of JNK 
























Figure 3.13. The percentage of moving mitochondria is not affected by the JNK 
pathway under oxidative stress conditions in vitro. A, Representative kymographs 
of mitochondrial transport with overexpression of JNK kinase (HepB2) or knockdown 
of JNK (Bsk RNAi) in response to H2O2. Anterograde transport is toward the right; 
retrograde transport is toward the left. B, The percentage of moving mitochondria is 
reduced with H2O2 treatment. Either overexpression of JNK kinase (HepB2) or 
knockdown of JNK (Bsk RNAi) does not rescue the defects. Number of plates is 
shown on bars. Each plate contains at least 5 cells. Error bars indicate mean ± SEM. 
Significance is determined by one-way ANOVA with Bonferroni’s post-test. *p<0.05, 




















Figure 3.14. The JNK pathway plays a role in the regulation of mitochondrial 
transport in vivo. A, Representative kymographs of mitochondrial transport with 
overexpression of JNK kinase (HepB2) or knockdown of JNK (Bsk RNAi) in response 
to paraquat. Anterograde transport is toward the right; retrograde transport is toward 
the left. B, Paraquat and/or overexpression of HepB2 produce a decrease in 
mitochondrial flux anterogradly. Knockdown of Bsk partially rescues the effect of 
paraquat. Both overexpression of HepB2 and knockdown of Bsk reduce retrograde 
flux. C, Anterograde velocity is reduced by paraquat or overexpression of HepB2, and 
knockdown of Bsk partially rescues the effect of paraquat. Retrograde velocity is 
reduced in both overexpression of HepB2 and knockdown of Bsk. Number of larvae is 
shown on bars. Error bars indicate mean ± SEM. Significance is determined by one-
















Figure 3.15. Mitochondrial duty cycle, run length, and percentage of moving are 
not affected by the JNK pathway in vivo. A, Paraquat treatment shows slightly 
reduction in retrograde duty cycle with a decrease of moving time; Knockdown of 
Bsk in response to paraquat shows a slightly increase of pause and a decrease of 
moving time. B, Retrograde run length is modestly reduced by paraquat treatment. 
Either overexpression of HepB2 of knockdown of Bsk does not show significant 
difference compared to controls. C, Paraquat treatment shows an increase of the 
percentage of stationary mitochondria, while either overexpression of HepB2 of 
knockdown of Bsk does not show significant difference. Number of larvae is shown 
on bars. Error bars indicate mean ± SEM. Significance is determined by one-way 


















Figure 3.16. Activation of the JNK pathway shows a decrease of mitochondrial 
density. A, Representative binary images of mitochondrial density with 
overexpression of HepB2 or knockdown of Bsk in response to paraquat treatment. B, 
Overexpression of HepB2 shows reduced integrated mitochondrial density compared 
to the control. Number of larvae is shown on bars. Error bars indicate mean ± SEM. 
Significance is determined by one-way ANOVA with Bonferroni’s post-test. **p < 


























3.8 Activation or down-regulation of the JNK pathway does not affect 
intracellular Ca2+ levels 
    Previous results provide evidence that ROS-induced defects of mitochondrial 
transport are mediated by Ca2+ and the JNK pathway (Section 3.6 and 3.7, above). 
However, it is not clear how Ca2+ and the JNK pathway might interact in the ROS 
regulation of mitochondrial transport. To determine whether the JNK pathway is 
upstream of Ca2+ signaling, I examined intracellular Ca2+ levels in primary neurons 
expressing GCaMP6 with either genetic activation or down-regulation of the JNK 
pathway in motor neurons.  
    Similar to previous results, these neurons showed about 50% higher GCaMP6 
intensity compared to controls after H2O2 treatment (Fig. 3.9 and 3.17). However, 
neither activation nor down-regulation of the JNK pathway affects intracellular Ca2+ 
levels (Fig. 3.17B), indicating that the JNK pathway is not upstream of the Ca2+ 
signaling. This suggests that the defects of mitochondrial transport caused by ROS-
induced Ca2+ levels are not mediated by the JNK pathway, and also raises the 























Figure 3.17 Activation or down-regulation of the JNK pathway does not affect 
intracellular Ca2+ levels. A, Representative Ca2+ imaging with overexpression of 
HepB2 or down-regulation of Bsk; Ca2+ is measured by the intensity of GCaMP6 
fluorescence. Scale bars indicate 10 µm. B, Quantitative results from (A). H2O2 
treatment produces an increase of Ca2+ levels, but neither overexpression of HepB2 
nor down-regulation of Bsk produces a significant difference in the result. Number of 
plates is shown on bars. Each plate contains at least 5 cells. Error bars indicate mean 
± SEM. Significance is determined by one-way ANOVA with Bonferroni’s post-test. 








CHAPTER 4. DISCUSSION 
    Although excess ROS produce varied damage to macromolecules, organelles and 
cells (Brookes et al., 2004; Court and Coleman, 2012), they are probably more in 
their important roles as signaling molecules at physiological levels (Lambeth and 
Neish, 2014; Nayernia et al., 2014). Mitochondria are the major source of ROS 
(Brookes et al., 2004; Bhat et al., 2015; Genova and Lenaz, 2015) and also are 
damaged by them: since ROS have been shown to affect mitochondrial transport, 
fission-fusion, and mitophagy in vitro (Jendrach et al., 2008; Fan et al., 2010; Fang et 
al., 2012; Frank et al., 2012), it is important to elucidate the underlying mechanisms 
linking these effects. In this study, I have focused on the relationship between ROS 
and mitochondrial transport, and have demonstrated fundamental mechanistic 
connections between these two. I find that: 1) ROS specifically reduce mitochondrial 
transport both in vitro and in vivo, and produce a decrease of mitochondrial length 
and membrane potential; 2) In addition to excess ROS, the reduction of physiological 
ROS levels by knockdown of the Nox family also induces defects in mitochondrial 
transport. 3) Excess ROS disturb neuronal Ca2+ homeostasis, increasing Ca2+ levels, 
which in turn inhibit mitochondrial transport and reduce mitochondrial length; 4) 
ROS-induced defects of mitochondrial transport are mediated by a signaling pathway. 
The JNK pathway in particular plays a role in the regulation of anterograde transport 
in the presence of excess ROS. 
 
4.1 Mitochondrial transport is preferentially affected by ROS 
    Mitochondrial axonal transport is reduced in the presence of excess ROS both in 
vitro and in vivo, primarily via reduced organelle flux and velocity (Fig. 3.1 – 3.3). 
More important, ROS preferentially affect mitochondria, since the transport of DCVs 







consistent with a previous in vitro study that though mitochondria and Golgi-derived 
vesicles show reduced mobility by ROS, mitochondrial transport is preferentially 
affected (Fang et al., 2012). Based on these studies, I propose that among the axonal 
transport cargoes, mitochondria are a prime target of ROS.  
    What possible mechanism could explain the specific sensitivity of mitochondrial 
transport to ROS? Unlike other axonal vesicles and organelles, mitochondria are 
linked to kinesin motor proteins via a complex of a mitochondrial Rho GTPase, Miro, 
and the adapter protein, Milton. When the intracellular Ca2+ levels increase, Ca2+ 
binds to the two EF-domains of Miro, causing a conformational change that disrupts 
the ability of kinesin to move the mitochondria but, interestingly, inhibiting both 
directions of mitochondrial transport (Macaskill et al., 2009; Wang and Schwarz, 
2009; Chen and Sheng, 2013). This regulation by Ca2+ is a major difference in the 
axonal transport of mitochondria versus other organelles, and prompted one of my 
areas of experimentation.  
    The JNK pathway might also affect mitochondrial transport more specifically. 
While several studies suggest that the JNK pathway affects general axonal transport 
via phosphorylation of kinesin or superior cervical ganglion 10 (SCG10), a 
microtubule binding protein in axons (Morfini et al., 2006; Shin et al., 2012), other 
studies suggest that there is a regulatory difference in transport between mitochondria 
and other cargoes. For example, mutants in APLIP1, the Drosophila homologue of a 
JNK-interacting protein (JIP), reduce general transport of cargoes in both directions, 
but reduce mitochondrial transport only in the retrograde direction, suggesting a 
unique regulatory feature of mitochondrial transport (Horiuchi et al., 2005). In 
addition, the alpha subunit of the heterotrimeric G protein G12 (Gα12) has been 
shown to stimulate JNK activity (Nagao et al., 1999); this is notable because Gα12 is 
targeted to mitochondria and itself affects mitochondrial motility (Andreeva et al., 
2008). These studies suggest the possibility that the JNK pathway has some specific 








4.2 ROS homeostasis is required for mitochondrial transport 
    In addition to elucidating the effects of excess ROS on mitochondrial transport, I 
have also provided evidence that ROS levels reduced below physiological conditions 
by knockdown of the Nox family also impaired mitochondrial transport (Fig. 3.6 and 
3.7). Interestingly, though knockdown of Nox and Duox reduces mitochondrial 
transport, the detailed motility phenotypes are different. Knockdown of Nox produces 
the general reduction in different parameters of transport in both directions, whereas 
knockdown of Duox affects general retrograde transport but only anterograde run 
length (Fig. 3.6 and 3.7). This suggests unique different regulatory features of 
mitochondrial transport. More specifically, Nox and Duox are both required for 
retrograde transport. However, Nox might play more important roles in the 
anterograde transport, since knockdown of Nox affects all parameters of anterograde 
transport. Knockdown of Duox only affect run length, suggesting that mitochondria 
spend more runs to reach the destination. Thus, it is possible that the role of Duox in 
the anterograde transport is to maintain efficient, continuous movement. It has been 
shown that myosin motors compete with microtubule-based motors and halt 
mitochondrial movement (Pathak et al., 2010). Whether Duox prevents competition 
between myosin and microtubule-based motors remains for further investigation. 
    What could explain the effects of Nox and Duox downregulation on mitochondrial 
transport? Since their main function is ROS production, knockdown of these enzymes 
reduces ROS levels below physiological levels. Under normal physiological 
conditions, ROS serve as important signaling molecules and regulate numerous 
cellular functions (Lambeth and Neish, 2014; Nayernia et al., 2014) (Section 1.2.2.2, 
above). Thus, it should not be surprising that knockdown of Nox and Duox impairs 
mitochondrial transport. Are there any signaling pathways or mechanisms that can be 
related to the impairment of mitochondrial transport by low ROS? One candidate is 
the PI3K/Akt/GSK3β pathway. This pathway has been shown to be activated by Nox-
released ROS (Nakanishi et al., 2014) and to stimulate mitochondrial transport (Chen 
et al., 2007). Thus, knockdown of Nox family, which reduces ROS levels, may be 








4.3 The ROS-induced effects on mitochondrial transport is mediated via 
changes of Ca2+ levels 
    As mentioned above (Section 1.1.4.1 and 4.1), cytosolic Ca2+ regulates 
mitochondrial transport. Here I have shown that excess ROS do increase Ca2+ levels 
(Fig. 3.9) and that Ca2+ chelation by EGTA rescues the defects of mitochondrial 
transport (Fig. 3.11A - D), consistent with Ca2+ inhibition of mitochondrial transport 
(Macaskill et al., 2009; Wang and Schwarz, 2009; Chen and Sheng, 2013).  
    It is notable that H2O2-induced high Ca2+ levels are rescued to physiological levels 
by the extracellular Ca2+ chelator EGTA (Fig. 3.11A and B), suggesting that the 
ROS-induced Ca2+ increase is caused by the Ca2+ influx from the extracellular 
environment. A likely explanation involves several Ca2+ channels on the plasma 
membrane that are regulated by redox balance (Görlach et al., 2015). For example, 
H2O2 treatment has been shown to induce Ca2+ influx through L-type or T-type 
voltage-dependent Ca2+ channels (VDCC) (Hudasek et al., 2004; Tabet et al., 2004) 
(Section 1.2.4.1). In addition to VDCC, ROS are known to stimulate Ca2+ influx 
through channels involved in receptor-induced Ca2+ signals such as transient receptor 
potential (TRP) channels and store-operated Ca2+ channels (SOC) mediated by Orai 
channel proteins (Hara et al., 2002; Grupe et al., 2010) (Section 1.2.4.1). Thus, I 
propose that elevated Ca2+ levels are induced by ROS through stimulating one or 
more Ca2+ channels on the plasma membrane.  
    While most studies have focused on the effects of elevated Ca2+ levels on 
mitochondrial transport (Macaskill et al., 2009; Wang and Schwarz, 2009; Chen and 
Sheng, 2013; Nguyen et al., 2014; Stephen et al., 2015), I found that experimentally 
decreased intracellular Ca2+ levels also produce a decrease of mitochondrial transport 
(Fig. 3.11E - H), indicating that normal Ca2+ homeostasis is important for 
mitochondrial transport. This might explain a previous study showing that the defects 
of mitochondrial transport induced by MPP+ are rescued by thio-antioxidant N-
acetylcystein (NAC; precursor of glutathione), whereas they are not rescued by a high 
concentration of EGTA (2.5 mM). The latter probably reduced Ca2+ levels below 








4.4 The ROS-induced defects of mitochondrial transport is mediated by the 
signaling pathway 
    Although Ca2+ levels regulate mitochondrial transport, I found that the defects of 
mitochondrial transport was not fully rescued by Ca2+ chelation (Fig. 3.11A - D), 
suggesting that other factors might be involved in ROS regulation of mitochondrial 
transport.  Indeed, several signaling pathways have been shown to regulate axonal 
transport. Axonal mitochondria are recruited in response to Nerve Growth Factor 
(NGF), and this recruitment is regulated in part via the phosphoinositide 3-kinase 
(PI3K) (Chada and Hollenbeck, 2004). Glycogen synthase kinase 3 (GSK3) can 
phosphorylate kinesin light chain (Klc) to inhibit axonal transport, whereas activation 
of Akt, which inhibits GSK3β, stimulates axonal mitochondrial transport (Morfini et 
al., 2002; Chen et al., 2007). In addition, activation of the JNK pathway 
phosphorylates kinesin heavy chain (Khc), reducing the interaction between kinesins 
and microtubules and thus inhibiting anterograde axonal transport (Morfini et al., 
2006) (Section 1.1.4.2).  
    Here I have shown that activation of the JNK pathway reduces anterograde 
mitochondrial transport, and that ROS-induced defects are rescued by knockdown of 
the JNK pathway (Fig. 3.14). This anterograde direction-specific regulation might be 
caused by the phosphorylation of kinesin by JNK (Morfini et al., 2006). In the 
retrograde direction, knockdown of the JNK pathway decreases mitochondrial 
transport (Fig. 3.14). It has been shown that JIPs are required for the stress-induced 
JNK activation (Yasuda et al., 1999; Whitmarsh et al., 2001; Taru et al., 2002), and 
the mutation of the Drosophila JIP homologue reduces mitochondrial transport only 
in the retrograde direction (Horiuchi et al., 2005). Thus, disruption of the JNK 
pathway either by knockdown of JNK or by mutation of a Drosophila JIP homologue 
is suggested to produce retrograde-specific defects of mitochondrial transport 
although the mechanism remains unknown.  
   Although I found that the JNK pathway plays a role in the regulation of ROS-
induced defects of mitochondrial transport, I have not excluded other signaling 
pathways from the regulation. Since ROS activate the PI3/Akt/GSK3β pathway 







pathway stimulates mitochondrial transport (Chen et al., 2007), I initially did not 
consider this pathway as a candidate. However, two recent studies have provided 
evidence that overexpression of GSK3β promotes mitochondrial transport (Llorens-
Martín et al., 2011; Ogawa et al., 2016), raising the possibility that ROS might also 
inhibit mitochondrial transport via the PI3/Akt/GSK3β pathway. 
    In addition to the effects on mitochondrial transport, activation of the JNK pathway 
reduces mitochondrial density (Fig. 8). This density reduction might involve 
upregulation of the mitophagic process. JNK has been shown to increase the 
expression of the mitophagy marker Bcl-2 E1B 19-KDa interacting protein 3 (BNIP3) 
in stressed cardiomyocytes (Chaanine et al., 2012), and to stabilize PINK1 on the 
mitochondrial outer membrane and subsequently activate mitophagy in stressed 
neuroblastoma cells (Park et al., 2016). These two results suggest that the reduced 
density might result from increased mitophagy produced by activated by JNK. 
 
4.5 How might Ca2+ and the JNK pathway interact in the ROS regulation of 
mitochondrial transport? 
    Several studies have shown that elevated intracellular Ca2+ levels activate the JNK 
pathway, and subsequently induce apoptosis or neurodegeneration (Kim and Sharma, 
2004; Sato et al., 2015; Zhang et al., 2015). However, it is possible that the JNK 
pathway is not simply downstream of Ca2+ signaling in the ROS regulation of 
mitochondrial transport. ROS could increase Ca2+ influx from extracellular 
environment by activating Ca2+ channels on the plasma membrane (Hara et al., 2002; 
Hudasek et al., 2004; Tabet et al., 2004; Grupe et al., 2010), and activate the JNK 
pathway via the mediation of ASK1 (Tobiume et al., 2001; Shen and Liu, 2006; Son 
et al., 2013), suggesting parallel, independent pathways of ROS-activated Ca2+ influx 
and JNK signaling. Activation or down-regulation of JNK signaling does not affect 
Ca2+ levels (Fig. 3.17), supporting the parallel hypothesis. In addition, Ca2+ inhibits 
mitochondrial transport in both directions (Macaskill et al., 2009; Wang and Schwarz, 
2009; Chen and Sheng, 2013), but activation of the JNK pathway inhibits 
mitochondrial transport in anterograde direction (Fig. 3.14). Since Ca2+ influx and the 







different effects on mitochondrial transport, it is likely that they regulate 
mitochondrial transport in parallel. 
 
4.6 Mitochondrial fission-fusion, metabolic state, and transport are 
interrelated in response to ROS 
    In addition to elucidating the mechanistic connection between ROS and 
mitochondrial transport, I have provided evidence that mitochondrial quality control 
is correlated with transport. I found that excess ROS and abnormal Ca2+ homeostasis 
impair mitochondrial transport (Fig. 3.1, 3.2, 3.3, 3.10, and 3.11A - D) and reduce 
mitochondrial length (Fig. 3.8A, B and 3.11E - J). Moreover, when mitochondrial 
transport is rescued either by SOD overexpression (Fig. 3.1 and 3.2) or by EGTA 
treatment (Fig. 3.11C, D), mitochondrial length is also rescued (Fig. 4A, B, and 6I, J). 
Previous studies have shown that the mutation of the mitochondrial fusion protein, 
Mitofusin, reduces mitochondrial length, impairs mitochondrial transport and 
increases Ca2+ levels in axons (Baloh et al., 2007; Misko et al., 2010; Misko et al., 
2012), consistent with our findings. These studies together reinforce the idea that 
mitochondrial fission-fusion and transport are highly interrelated. This 
interrelationship between fission-fusion and transport is possibly related to 
Miro/Milton complex since Mitofusin can interact with Miro/Milton complex, and the 
transport defects produced by knockdown of Miro is similar to the defects caused by 
knockout of Mitofusin (Misko et al., 2010).   
    This study also provides evidence that both mitochondrial membrane potential and 
transport are reduced in response to ROS (Fig. 3.1 - 3.3), suggesting an association 
between these two. This idea is supported by other studies in neurodegenerative 
disease models. For example, in a Drosophila model of Friedreich Ataxia, reduced 
frataxin expression produce defects in mitochondrial transport and membrane 
potential; PINK1 mutation also reduces both mitochondrial transport and membrane 
potential. (Shidara and Hollenbeck, 2010; Devireddy et al., 2015). In addition, in 
mammalian primary neurons, cells treated by ATPase blocker oligomycin or by an 
uncoupler (FCCP or CCCP), which inhibits mitochondrial electron transport, produce 







These studies show that defects in mitochondrial membrane potential are 
accompanied with defects in mitochondrial transport, suggesting the interplay 
between them. 
    In conclusion, I have provided evidence that oxidative stress not only affects 
mitochondrial morphology and membrane potential, but also reduces mitochondrial 
axonal transport both in vitro and in vivo. These defects in mitochondrial transport are 
caused by an imbalance of Ca2+ homeostasis and activation of the JNK pathway. 
Furthermore, under physiological conditions, ROS homeostasis is important for 
mitochondrial transport. Thus, our study establishes the mechanistic links between 
ROS and mitochondrial transport, and suggests a possible new and more subtle role 
for ROS in the induction of neurodegeneration, which will suggest new strategies to 
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